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TIIVISTELMÄ
Skitsofrenia on vakava mielenterveyden häiriö. Skitsofreniaa esiintyy kaikkialla maailmas-
sa. Skitsofrenian esiintyvyys vaihtelee, mutta elinaikainen sairastumisriski on keskimäärin
0,4-0,7%. Perinnöllinen alttius on sairauden merkittävä riskitekijä. Jos perheen molemmat
vanhemmat ovat sairaita, on lapsen sairastumisriski 50-kertainen väestötason riskiin näh-
den.
Skitsofrenian selvästi havaittavia (positiivisia) oireita ovat aistiharhat, harhaluulot, outo
käyttäytyminen sekä ajatushäiriöt. Muita (negatiivisia) oireita ovat tunne-elämän latistu-
minen, puheen köyhtyminen, tahdottomuus ja mielihyvän menestys (anhedonia). Skitsofre-
nian oirekuva vaihtelee suuresti potilaasta toiseen. Skitsofrenia voidaan tunnistaa kohtuulli-
sen luotettavasti, vaikka diagnoosiin ei ole käytettävissä mitään yksiselitteistä testiä kuten
laboratoriokoetta.
Väitöskirjatyössä keskityttiin tutkimaan skitsofrenian elinaikaista esiintyvyyttä,
ilmaantuvuutta ja diagnoosien luotettavuutta sekä skitsofrenian ilmiasua ja periytyviä
piirreominaisuuksia (fenotyyppiä) Kuusamosta lähtöisin olevissa perheissä. Tämä
väitöskirjatyö on osa laajempaa Kansanterveyslaitoksen vakavien mielenterveyden häiriöiden
geneettistä epidemiologiaa ja molekyyligenetiikkaa koskevaa hanketta, jota toteutetaan
Mielenterveyden ja Alkoholitutkimuksen osastolla yhteistyössä Molekyylilääketieteen
osaston kanssa.
Tutkimusaineisto muodostettiin sairaaloiden hoitoilmoitusrekisteristä sekä Kansaneläkelai-
toksen ilmaislääke- ja eläkerekistereistä. Tutkimukseen valittiin ne vuosina 1940-76 syn-
tyneet potilaat, joilla oli ainakin yhdessä kolmesta rekisteristä skitsofreniaan viittaava diag-
noosi (skitsofrenia, skitsoaffektiivinen tai skitsofreniforminen psykoosi). Näille potilaille
etsittiin väestörekisteristä perhetiedot, ja edelleen perheenjäsenille rekisteritiedot. Näin löy-
dettiin yhteensä 33731 potilasta Suomesta. Heistä muodostettiin kaksi tutkimusryhmää:
Kuusamosta (ns. isolaatista) lähtöisin olevat 658 potilasta sekä 4904 potilasta koko Suo-
mesta perheistä, joissa oli vähintään kaksi sairasta sisarusta. Aineiston vertailuryhmä saatiin
suomalaista aikuisväestöä edustavasta Terveys 2000-tutkimuksesta.
8Sairauskertomukseen perustuva konsensusdiagnoosi määriteltiin kaikille tutkimusryhmien
potilaille, joilta saatiin verinäyte molekyyligeneettisiä tutkimuksia varten. Konsensusdiag-
noosia varten tilattiin sairauskertomukset psykiatrisesta erikoissairaanhoidosta ja peruster-
veydenhuollosta. Potilaisiin ja heidän omaisiinsa otettiin uudelleen yhteyttä, ja heille tehtiin
strukturoidut diagnostiset ja oirekuvaa kartoittavat haastattelut sekä neuropsykologisia tes-
tauksia. Lisäksi jokaista skitsofreniaa sairastavaa potilasta kohden tutkittiin myös vähintään
yksi rekisteritietojen mukaan terve sisarus. Isolaatissa arvioitiin myös sisarusten terveyden-
tilaa ja psykoottisten häiriöiden ilmaantuvuutta 7-11 vuoden aikana.
Skitsofrenian esiintyvyys oli isolaatissa kansainvälisesti korkea sekä rekisterien (1,5%),
konsensusdiagnoosien (0,9-1,3%) että haastattelun (0,7-1,2%) perusteella. Skitsofrenia-
diagnoosi piti konsensusdiagnoosin perusteella paikkansa 69%:lla ja haastattelun perusteel-
la 63%:lla niistä potilaista, joilla oli rekisteritietojen perusteella skitsofrenia, skitsoaffektii-
vinen tai skitsofreniforminen psykoosi. Ne skitsofreniaa sairastavat potilaat, joilla oli sairai-
ta sisaruksia, edustivat familiaalista skitsofreniaa. Siihen liittyi korostetusti skitsofrenian
negatiivisista oireista tunteiden latistumista ja puheen köyhtymistä. Toisaalta isolaatista läh-
töisin olevien potilaiden oirekuvassa oli vähemmän skitsofrenian positiivisia oireita eli ais-
tiharhoja ja harhaluuloja kuin koko maan monisairaiden perheiden potilailla. Rekisteritieto-
jen mukaan terveistä sisaruksista 16% sairasti haastattelun perusteella psykoottista häiriötä.
Heistä 7,7%:lla oli ollut psykoottisia oireita jo ennen rekisteritietojen seulontaa ja lisäksi
8,7% oli saanut psykoosidiagnoosin suhteellisen pian seurannan aikana ennen tutkimuksen
alkua.
Yhteenvetona todetaan, että skitsofrenian esiintyvyys oli tarkasti geneettisesti määritellyssä
isolaatissa kansainvälisesti korkea kolmella eri menetelmällä arvioituna. Uusina löydöksinä
tuli esiin myös se että, isolaatin potilaiden oirekuvassa oli vähemmän harhaluuloja ja aisti-
harhoja kuin koko maan monisairaiden perheiden potilaissa. Tämä ilmiasu saattaa ilmentää
skitsofrenian periytyvää piirreominaisuutta. Pelkästään rekisteritietoja ei voida käyttää skit-
sofreniaa sairastavien potilaiden terveiden sisarusten seulontaan geneettisiä tutkimuksia
varten, koska 7,7%:lla terveistä sisaruksista oli haastattelun perusteella psykoottisia oireita
jo ennen seulontaa. Geneettisiä tutkimuksia varten rekisteridiagnoosit on siten varmennetta-
va diagnostisella haastattelulla tai sairauskertomuksista johdettavan konsensusdiagnoosin
avulla. Strukturoitua haastattelua suositellaan myös kliiniseen käyttöön parantamaan diag-
noosien luotettavuutta sekä silloin, kun skitsofreniaa sairastavan potilaan lähiomainen hakee
apua päihde- tai mielenterveyden ongelmiin.
Asiasanat: skitsofrenia, esiintyvyys, diagnoosi, oireet
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APA       American Psychiatric Association
BPRS      Brief Psychiatric Rating Scale
CI        Confidence Interval
CODE-295  Register diagnosis of schizophrenia, schizoaffective or schizophreniform disorder
CPRS      Comprehensive Psychopathological Rating Scale
DSM       Diagnostic and Statistical Manual of Mental Disorders
DSM-III   Diagnostic and Statistical Manual of Mental Disorders, Third Edition
DSM-III-R Diagnostic and Statistical Manual of Mental Disorders, Third Edition-Revised
DSM-IV    Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition
GAF       Global Assessment of Functioning
GEE       General Estimation Equations
ICD       International Classification of Diseases
ICD-8     International Classification of Diseases, Eight Edition
ICD-9     International Classification of Diseases, Ninth Edition
ICD-10    International Classification of Diseases, Tenth Edition
IM        Isolate Multiplex patients
IS        Isolate Singleton patients
MSSS      Major Symptoms of Schizophrenia Scale
NOS       Not otherwise specified
NM        National (whole country) Multiplex patients
OCCPI     Operational Criteria Checklist for Psychotic Illness
OPCRIT    Computer program for the OCCPI
OR        Odds Ratio
p, p-value Significance Probability
PANSS     Positive and Negative Syndrome Scale
PSE       Present State Examination
RDC       Research Diagnostic Criteria
SANS      Scale for the Assessment of Negative Symptoms
SAPS      Scale for the Assessment of Positive Symptoms
SCID      Structured Clinical Interview for DSM
SD        Standard Deviation
SDS       Schedule for the Deficit Syndrome
WHO       World Health Organization
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1. ABSTRACT
Schizophrenia is a severe mental disorder, its prevalence averaging 0.4-0.7% worldwide.
The largest and best documented risk factor related to the development of schizophrenia is
genetic risk. The lifetime risk of schizophrenia increases with each affected relative, up
to nearly 50% when both parents are affected. Schizophrenia is a complex clinical
syndrome. It can be recognized and defined with reasonable agreement but we have no
laboratory or other objective test to diagnose it. The present study focuses on the
assessment of prevalence of schizophrenia, on the reliability of the schizophrenia
diagnosis, on phenotype analysis, and on the signs and symptoms of schizophrenia in an
isolate. We also investigated whether siblings of patients with schizophrenia can be
identified as not having any psychotic disorder using health care register information
only. This study is part of a larger investigation called "The Genetic Epidemiology and
Molecular Genetics of Schizophrenia in Finland", conducted at the National Public Health
Institute as a collaboration between the Department of Mental Health and Alcohol Research
and the Department of Molecular Medicine.
In our study we utilized three nationwide health care registers: 1) the Hospital Discharge
Register, 2) the Free Medication Register, and 3) the Disability Pension Register, plus
the National Population Register, in order to identify all schizophrenia patients born
from 1940 to 1976 (N=33731) in Finland, and their first-degree relatives. Patients with
at least one parent born in a specific genetic homogeneous isolate in north eastern
Finland were identified, as well as familial schizophrenia patients with at least two
affected siblings from the whole country. In addition, the study included a
population-based comparison group derived from the Health 2000 Study. Between 1991 and
2002 we contacted all isolate patients (N=658) and multiplex patients (N=4904) from the
whole country with at least two affected siblings in the family in order to take blood
samples for genetic studies. We also collected case records and reassessed the register
diagnosis. Were recontacted the isolate patients and a random sample of multiplex patients
from the whole country in 1998-2002 to make diagnostic clinical interviews and to assess
11
the negative and positive symptoms and signs of schizophrenia for phenotype studies. We
also interviewed siblings of schizophrenia patients who were initially healthy according
to the Hospital Discharge Register. We followed them for seven to 11 years to monitor any
emergence of psychotic disorders.
Our main findings were that the prevalence of schizophrenia was relatively high based on
register (1.5%), case record (0.9-1.3%), and interview data (0.7-1.2%). Of those with a
register diagnosis of schizophrenia, schizoaffective or schizophreniform disorder, 69%
received a record-based consensus diagnosis and 63% an interview diagnosis of
schizophrenia. Schizophrenia patients with first-degree relatives with psychotic disorder
had more severe affective flattening and alogia as negative symptoms than those who were
the only affected individuals in their family. However, isolate patients had less positive
symptoms than the whole Finland familial patient group. When we interviewed the initially
healthy siblings of schizophrenia patients, the emergence of illness in these siblings
during a relatively short follow-up was high (8.7%). In addition, 7.7% of siblings had
psychotic symptoms already before the register diagnoses were identified in 1991.
The prevalence of schizophrenia in the genetically homogeneous isolate assessed using
three methods was relatively high. A novel finding was that the isolate patients,
regardless of their familial loading for schizophrenia, had less delusions and
hallucinations than the whole country familial patients, which may be related to the
genetic homogeneity in the isolate. This phenotype feature encourages the use of
endophenotypes in genetic studies instead of reliance of diagnoses alone. In addition, we
found that the absence of register diagnosis cannot be used in molecular genetic studies
to confirm that siblings are healthy. For genetic research the register diagnosis should
be reassessed using either a structured interview or a best-estimate case note consensus
diagnosis. Structured clinical interview methods should be used also when first-degree
relatives of schizophrenia patients seek help for any mental, alcohol or substance use
problems.
Keywords: schizophrenia, prevalence, diagnosis, familial, phenotype, symptoms, isolate
12
2. LIST OF ORIGINAL PUBLICATIONS
This thesis is based on the following original publications.
I    Arajärvi R,  Suvisaari J,  Suokas J,  Schreck M,  Haukka J, Hintikka J, Partonen T,
     Lönnqvist J.  Prevalence  and  diagnosis  of  schizophrenia  based  on register, case
     record   and   interview   data  in  an   isolated   Finnish   cohort   born   1940-1969.
     Social Psychiatry and Psychiatric Epidemiology 2005, 40:808-816.
II   Arajärvi R,  Haukka J,  Varilo T,  Suokas J,  Juvonen H,  Suvisaari J,  Muhonen M,
     Suominen K, Tuulio-Henriksson A, Schreck M, Hovatta I, Partonen T, Lönnqvist J.
     Clinical phenotype of schizophrenia in a Finnish isolate.
     Schizophrenia Research, 2004; 67:195-205.
III  Arajärvi R,   Varilo T,  Haukka J,   Suvisaari J,  Suokas J,  Juvonen H,  Muhonen M,
     Suominen K, Hintikka J, Schreck M, Tuulio-Henriksson A, Partonen T, Lönnqvist J.
     Affective  Flattening  and  alogia  associate  with the familial form of schizophrenia.
     Psychiatry Research 2006;141:161-172.
IV   Arajärvi R,   Ukkola J,   Haukka J,   Suvisaari J,   Hintikka J,   Partonen T, Lönnqvist J.
     Psychosis among "healthy" siblings of schizophrenia patients.
     BioMedCentral Psychiatry 2006;6:6
13
3. INTRODUCTION
Schizophrenia is a severe mental disorder, the prevalence of which varies from 0.4 to 0.7%
worldwide (Saha et al. 2005). Schizophrenia often begins early in life and leads to severe
psychosocial impairment. It brings great suffering for both patients and their families.
First degree relatives of schizophrenia patients have 10-fold risk of developing
schizophrenia compared to the general population (Austin 2005, Gottesman 1994, Kendler et
al. 1993a,b, 2000, Varma 1997). Certain environmental risk factors also increase the risk
of schizophrenia. Some of these risk factors operate on an individual level and some on a
societal level, but all need to be considered in the context of schizophrenia as a
lifelong brain disorder (Cannon and Clarke 2005). However, the etiology and
pathophysiology of schizophrenia remain to be elucidated.
It has become relatively simple to localize and characterize genes for monogenic
disorders. However, the situation is quite different in complex psychiatric disorders,
which are influenced by multiple genes and their interactions. Finding susceptibility genes
for complex disorders may be possible by using trait-like variables associated with the
disorder as phenotypes in genetic studies. This effort to identify intermediate phenotypes
or endophenotypes is driven by the idea that they involve the same biological pathways as
the disorder but are closer to the relevant gene action than the categorical diagnoses,
thus adding power to genetic studies. The endophenotypes are assumed to have a simpler
genetic architecture than their corresponding disorder (Freedman et al. 1999). An
endophenotype may be neurophysiological, biochemical, endocrinological, neuroanatomical,
cognitive, neuropsychological or a personality trait, and it may provide simpler clues to
the genetic and environmental underpinnings than the disease syndrome itself. Hence, in
patients and their apparently healthy first-degree relatives it should be more prevalent
than in the general population (Weiser et al. 2005b).
The signs and symptoms of schizophrenia are diverse and almost every aspect of cognition
and behavior are affected (see Appendix 1, 2 and 3). No single one of these many signs and
symptoms can be considered to be pathognomonic. Unfortunately, we have no laboratory or
other objective tests to diagnose schizophrenia and thus accurate observation and
recording of signs and symptoms is generally the only way of forming a reliable diagnosis
of schizophrenia. However, each symptom is present in some patients, but none is present
in all. Schizophrenia is a heterogeneous "group of schizophrenias" (Andreasen 1995,
Andreasen et al. 1995a). The complexity of schizophrenia is so great that some early
14
investigators challenged whether it could be defined with adequate precision to achieve
good reliability among clinicians and investigators (Kreitman et al. 1961, McCormick and
Flaum 2005). However, the World Health Organization and the American Psychiatric
Association produced criterion-based systems for diagnosing schizophrenia that have been
shown to improve reliability. The most recent versions were used in this study (World
Health Organization 1993, American Psychiatric Association 1994).
"The Genetic Epidemiology and Molecular Genetics of Schizophrenia in Finland" project, was
initiated in 1988. For our study we selected one of the largest rural municipalities in
the eastern part of Finland, known to have a high prevalence of schizophrenia. Its
population (17000) has a history of isolation, making it genetically homogeneous and thus
providing an excellent basis for genetic studies. It also has a straightforward health
service system ideal for clinical study purposes. The current thesis forms part of that
project.
15
4. REVIEW OF THE LITERATURE
4.1 Epidemiology of schizophrenia
4.1.1 Prevalence of schizophrenia
Although schizophrenia occurs throughout the world, its prevalence has been reported to
vary considerably. Torrey (1987) published a review article including 70 prevalence
studies. In the latest systematic review of the prevalence of schizophrenia Saha and
colleagues (2005) identified 188 studies from 46 countries published 1965-2002. The median
values per 1000 persons (10%-90% percentiles) for the distributions of point, period,
lifetime, and lifetime morbid risk were 4.6 (1.9-10.0), 3.3 (1.3-8.2), 4.0 (1.6-12.1),
and 7.2 (3.1-27.1), respectively (Saha et al. 2005). Studies with the highest quality
scores had significantly higher prevalence estimates. The median value for lifetime
prevalence of schizophrenia was 0.40%, with a range of 0.2-1.2%. Prevalence estimates
varied considerably. The review paper of Goldner and colleagues (2002) estimated the
prevalence rates from 18 studies. The lifetime prevalence of schizophrenia varied from
0.12% (Chen et al. 1993) to 1.6% (Canino et al. 1987) and that of schizophrenia spectrum
disorders from 0.4% (Oakley-Brown et al. 1989) to 2.2% (Lehtinen et al. 1990). In the
Goldner et al. (2002) study, the best-estimate rate for lifetime prevalence of
schizophrenia, 0.55% (0.37-0.8), was higher than Saha and colleagues (2005) found. The
lifetime prevalence varied 13-fold. The lowest prevalence rates of schizophrenia were
found in Asian populations (Hwu et al. 1989, Oaklay-Brown et al. 1989).
In Finland the lifetime prevalence of schizophrenia was 1.3% in the Mini-Finland Health
Survey, which used the Present State Examination interview (Lehtinen et al. 1990), and
1.2% in our earlier register based study (Hovatta et al. 1997). Geographically, the
prevalence is highest in eastern and northern Finland and lowest in the southwest
(Salokangas et al. 1987, Lehtinen et al. 1990, Hovatta et al. 1997, Korkeila et al. 1998).
In addition, the prevalence of schizophrenia was reported to be 1.7% in one isolate in
North Sweden, which was founded by three Finnish families in the early 17th century (Böök
et al. 1978, Jokipii 1992).
In isolated populations, the lifetime prevalence has varied from 0.1% (Chen et al. 1993)
to 2.2% (Hovatta et al. 1997). Some religious groups have very low prevalence estimates,
e.g. 0.03% for Amish (Egeland and Hostetter 1983) and 0.13% for Hutterite individuals
(Nimgaonkar et al. 2000). There is also small area variation in the prevalence rates of
schizophrenia within homogeneous populations, such as communities in rural Ireland
(Youssef et al. 1999, Scully et al. 2004).
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4.1.2 Incidence of schizophrenia
The incidence of a disease is a measure of the number of new cases that occur in a
population over a given period of observation. Cumulative incidence is an estimate of the
probability of the occurrence of an outcome over a specified period of time. The incidence
of schizophrenia was estimated in a systematic review article of McGrath et al. (2004a).
They analyzed 55 core studies from 33 countries finding, a median value (10%-90%
percentiles) for incidence of 15.2 (7.7-43.0) per 100 000 person years. Males had a
significantly higher incidence rate than females, while urban born and migrants had higher
rates than rural and native-born individuals.
In Finland, the incidence of schizophrenia and schizophreniform disorder was estimated to
be 36 per 100 000 person years by Salokangas (1993), and 69 per 100 000 person years for
all non-affective psychotic disorders based on the Finnish Hospital Discharge Register
(Korkeila et al. 1998). According to a register based study of Finnish birth cohorts born
1954-1965, the incidence of schizophrenia has declined in Finland (Suvisaari et al. 1999),
which suggests that some risk factors may have diminished in intensity.
4.1.3 Schizophrenia and migration and geographical variation in occurrence
of schizophrenia
The meta-analysis and review by Cantor-Graae and Selten (2005) confirmed that personal or
family history of migration is a risk factor for schizophrenia.
The rural/urban disparity in the occurrence of schizophrenia is marked; prevalence and
incidence rates are repeatedly found to be higher in urban areas (Mortensen et al. 1999,
Schelin et al. 2000, McGrath et al. 2004a). Both urban birth and upbringing have been
associated with increased risk of developing schizophrenia in adulthood (Lewis et al.
1992, Marcelis et al. 1998, Mortensen et al. 1999, Van Os et al. 2001). However, Saha and
colleagues (2005) found significant difference in incidence but no difference in
prevalence of schizophrenia between urban, rural and mixed sites. Native-born and
individuals from "least developed countries" had lower prevalences of schizophrenia than
immigrants or individuals from "emerging" or "developed" countries.
Finland appears to be an exception in this regard, as both the prevalence and incidence
rates of schizophrenia have been higher in rural areas (Suominen 1975, Lehtinen et al.
1990). However, in a more recent study the incidence among cohorts born 1965-1969 seemed
to be already higher in urban-born than rural-born individuals, contrasting with a higher
incidence in rural cohorts born in the 1950s (Haukka et al. 2001).
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4.1.4 Gender differences in prevalence and age of onset of schizophrenia
In a meta-analysis Aleman and colleagues (2003) analyzed 38 studies and provided evidence
for a sex difference in the risk of developing schizophrenia. The risk remained
significantly higher in men after controlling for potentially confounding factors.
However, Saha and colleagues (2005) found no difference between males and females in their
systematic review of the prevalence of schizophrenia.
Depending on the operational definition of illness onset, age at onset was 3.2-4.1 years
higher for women than men (Häfner 2003). However, several previous Finnish studies have
found no gender differences in the age of onset (Hovatta et al. 1997, Salokangas 1993,
Suvisaari et al. 1998).
4.2 Methods of assessing genetic and environmental risk factors
4.2.1 Family studies
Family studies of schizophrenia have established that schizophrenia strongly aggregates in
families. The lifetime risk increases with each affected relative, to nearly 50% when both
parents are affected (McGuffin et al.1995).
Pooled data from more than 40 Western European systematic family and twin studies between
1920 and 1987 suggest that the lifetime risk of schizophrenia in siblings of schizophrenic
probands is about 9% (Gottesman 1994). The Roscommon study (Kendler et al. 1993a), which
interviewed patients with schizophrenia and their first-degree relatives, found a 9.2%
morbid risk of schizophrenia in siblings. The overall risk of an interview-based diagnosis
of schizophrenia was 6.5% among relatives. The risk for all non-affective psychosis was
10.0%. Varma and colleagues (1997) found that the morbid risk of schizophrenia in siblings
was 8.7% in a study of 1089 first-degree relatives of schizophrenic patients.
The current evidence suggests that familial liability to schizophrenia increases not only
the risk of schizophrenia as narrowly defined, but also that of personality disorders of
the schizophrenia spectrum and probably several psychotic illnesses, including major
depressive disorder with psychotic features (Kendler et al. 1993a,b, 2000, Cardno et al.
2002a, Chang et al. 2002, Weiser et al. 2005a).
In high-risk studies, individuals - usually the offspring of schizophrenia patients - with
higher risk of developing schizophrenia than in the general population, are identified in
childhood and followed to adulthood through the risk period for developing schizophrenia.
The best known high-risk studies are the Copenhagen High Risk Project (Cannon and Mednick
1993), the New York High-Risk Project (Erlenmeyer-Kimling et al. 1997), and the Israeli
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High-Risk Study (Ingraham et al. 1995); the cumulative incidence of schizophrenia in these
studies was 16.2%, 13.1%, and 8.0%, respectively. Results from all the high-risk studies
support the familial liability to schizophrenia.
Finland’s Helsinki High-Risk Study analyzed offspring born between 1960 and 1969 to
mothers with schizophrenia, schizoaffective disorder, other schizophrenia-spectrum
disorders, or affective disorders. The cumulative incidence of schizophrenia was 6.7%
among the offspring of mothers with schizophrenia. The offspring of mothers with a
psychotic disorder had a heightened risk of developing a wide range of severe mental
disorders (Niemi et al. 2004).
4.2.2 Twin studies
Twin studies are based on the assumption that monozygotic (MZ) and dizygotic (DZ) twins
share a common environment to approximately the same degree. However, MZ twins are
genetically identical, whereas DZ twins are like siblings and have on average only half of
their genes in common. Sullivan and colleagues (2003) assessed in their meta-analysis of
12 published twin studies of schizophrenia that the point estimate of heritability in
liability to schizophrenia was high, at 81% (95% CI 73%-90%), and they also determined
that there was small but significant and interesting common environmental effect on
liability to schizophrenia: 11% (95% CI 3%-19%). In a Finnish twin cohort born from 1940
to 1957 with 2495 monozygotic and 5378 same-sex dizygotic twin pairs the lifetime
prevalence of schizophrenia was 2%; the heritability estimate for liability to
schizophrenia was 83% for genetic factors and the remaining 17% was due to unique
environmental factors (Cannon et al. 1998). The heritability estimates in these studies
are, of course limited to twins.
4.2.3 Adoption studies
Adoption studies can clarify the role of genetic and environmental factors in the
transmission of schizophrenia by examining two kinds of rare but informative
relationships: individuals who are genetically related but do not share a
familial-environmental factor, and individuals who share familial-environmental factors
but are not genetically related (Kendler 2000).
The largest study to use the affected adoptee design was the Danish Adoption Study of
schizophrenia (Kendler and Gruenberg 1984, Kety et al. 1994). The findings included a
10-fold greater prevalence of schizophrenia among biological than control relatives of
adoptees with chronic schizophrenia as well as other schizophrenia spectrum disorders.
The largest study using the affected biological parent design was the Finnish Adoptive
Study of Schizophrenia (Tienari and Wynne 1994, Tienari et al. 2000, 2003), which found a
significantly greater lifetime prevalence, 6.7%, among 164 index adoptees compared with a
2% prevalence of schizophrenia among 197 control adoptees. The genetic liability extended
to a broad spectrum of other psychotic and non-psychotic disorders.
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4.3 Symptoms and signs of schizophrenia
The signs and symptoms of schizophrenia are complex and diverse, encompassing almost
every aspect of cognition and behavior. To simplify the complexity, schizophrenia has been
divided into negative and positive symptoms (Andreasen 1983, 1984) (see also Appendix 2
and 3). However, when the inter-relationship between these negative and positive symptoms
was studied using factor analysis, it was recognized that positive symptoms should be
further subdivided into "psychotic" and "disorganized" groups (Andreasen et al. 1995a,b).
Grube and colleagues (1998) also found these three factors in their meta-analysis, which
included 10 factor analytic studies from the years 1982 to 1993. Further, subdivisions of
symptoms and signs of schizophrenia have been analyzed in several studies to improve the
phenotype description for genotype studies. Positive symptoms have been divided into
hallucinations and delusions. Kimhy and colleagues (2005) further divided delusions into
three factors; delusions of influence, self-significance, and persecution. Negative
symptoms have also been divided into several factors (Blanchard and Cohen 2005).
In a Helsinki High-Risk follow-up, 179 offspring were born to mothers with schizophrenia,
schizoaffective disorder, other schizophrenia spectrum disorders, and affective psychoses.
Maternal symptoms were analyzed and divided into four factors: negative, positive,
catatonic and affective symptoms. High maternal positive symptoms were found less harmful
to the child than other psychotic symptoms (Niemi et al. 2004). Salokangas (1997) analyzed
156 first-contact patients and re-examined them two and five years thereafter. He found
five major dimensions: a fairly stable negative dimension, plus delusional, hallucinatory,
disorganization, and depressive dimensions. The negative dimension was already present at
the onset of the disorder. However, the syndrome structure was more complex and varied
considerably with the duration of the illness.
A variety of instruments have been used to assess symptoms of schizophrenia. These
instruments include the Positive and Negative Syndrome Scale (PANSS) for schizophrenia
(Kay et al. 1987), the Comprehensive Psychopathological Rating Scale (CPRS) (Åsberg et
al. 1978), the Brief Psychiatric Rating Scale (BPRS) (Overall and Gorham 1962, Hedlund and
Vieweg 1980), the Major Symptoms of Schizophrenia Scale (MSSS) (Kendler et al. 1993a),
and the Schedule for the Deficit Syndrome (SDS) (Kirkpatrick et al. 1989).
We concentrated on studies which have used the Operational Criteria Checklist for
Psychotic Illness (OCCPI) (McGuffin et al. 1991) or the Scale for the Assessment of
Negative Symptoms (SANS) (Andreasen 1983) and the Scale for the Assessment of Positive
Symptoms (SAPS) (Andreasen 1984).
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4.3.1. Studies based on the Operational Criteria Checklist for Psychotic
Illness
The Operational Criteria Checklist for Psychotic Illness (OCCPI), is an instrument that
has been widely used in phenotype definition (Table 1). It has a categorical definition of
symptoms and no built-in positive or negative subscales. Most of the studies have found
four or five factors in the factor analysis, including negative, positive and disorganized
factors. Some of the findings are presented in Table 1. Familial aggregation was found for
negative symptoms (Van Os et al. 1997, Cardno et al. 2001, Wickham et al. 2001), and for
disorganized symptoms (Cardno et al. 1997, 2001, Wickham et al. 2001). Serretti et al.
(1996) replicated the factor analysis in two independent large samples and found that the
four-factor structure had strong construct and content validity. However, Serretti and
Olgiati (2004) later added the negative factor to the symptomatology of major psychosis.
Symptom factors also correlated with clinical variables (Van Os et al. 1999, Rosenman et
al. 2000, McIntosh et al. 2001).
In addition, Kendler and colleagues (1998) combined the OCCPI and the Major Symptoms of
Schizophrenia Scale (MSSS) and found that relatives had increased risk of schizophrenia
but also of a wide range of psychotic disorders.
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Table 1. Factor analytic studies based on Operational Criteria Checklist for Psychotic
Illness (OCCPI)
Authors         Country  N       Male    Mean  Diagnostic  Diagnoses Number of  Number and names of the 
and year                        % age    method                included    factors
of study                                   years                 Liability  OCCPI
                                                                   classes6)  items  
   Cardno et       UK         102     67 %    45.1   DSM-III-R1)   Lc 1       21          5: Paranoid, negative,
   al. 1996                                                                          disorganization,
                                                                                          first-rank delusions,
                                                                                          hallucinations
   Serretti et     Italy      1004    56 %    42.1   DSM-III-R1)   Lc 1-4     38          4: excitement, depression,
   al. 1996              (500+                                                       disorganization, delusion
                              504)
   Cardno et       UK         66      58 %    36.6   RDC2)    Lc 1-4     19          8: positive formal thought,
   al. 1997                                                                          first-rank delusions,
                                                                                          -hallucinations,
                                                                                          inappropriate affect/
                                                                                          bizarre behavior, negative,
                                                                                          grandiose/bizarre delusions,
                                                                                          delusions of influence/
                                                                                          persecution,
                                                                                          and other hallucinations
   Van Os et       UK         150+    64 %    26.4   RDC2)    Lc 1-4     20          7: inappropriate-catatonia,
   al. 1997              548                                                         delusions-hallucinations,
                              first-                                                       mania, insidious-blunting,
                              degree                                                       depression, lack of insight,
                              rela-                                                       paranoid delusions
                              tives
   Kendler et      Ireland    343+    64 %    42.3   DSM-III-R1)   Lc 1-4     OCCPI+      6: classic schizophrenia,
   al. 1998              942                                             MSSS7)      depression, schizophreniform,
                              first-                                           items       bipolar-schizomania,
                              degree                                                       schizophrenia-depression,
                              rela-                                                       hebephrenia
                              tives
   Cardno et       UK         191     70 %    42.0   DSM-IV3)    Lc 1-2     26          4: positive, disorganization,
   al. 1999                                                                          negative,first-rank delusions
   Serretti and    Italy      108     41 %    52.2   DSM-III-R1)   Lc 3,only   11          4: core depressive,
   Olgiati 1999                                                                          hallucinations, delusions,             delusional
                                                                   disorder               irritability symptoms
   Van Os et       UK         706     57 %    36.0   RDC2) and    Lc 1-4     46          5: Manic, depressive,
   al. 1999                                     DSM-III-R1)                          negative, positive,
                                                                                          disorganized symptoms
   Rosenman et     Australia   980     60 %    39.3   DSM-III-R1)   Lc 1-4     64          5: dysphoria, positive,
   al. 2000                                                                          substance use, mania, negative
   Cardno et       UK         224     54 %    46.5   RDC2)    Lc 1-4     18          6: positive, negative,
   al. 2001              twin                                                        disorganization, manic,
                              pairs                                                       depressive, general psychotic
   McIntosh et     UK         204     48 %    26.6   ICD-94)    Lc 1-4     39          4: manic, depression,
   al. 2001                                                                          disorganization,
                                                                                          reality distortion
                                                                                          (no negative items in analysis)
   Serretti et     Italy      2241    45 %    41.7   DSM-IV3)    Lc 1-4     46          4: excitement, delusions,
   al. 2001                                                                          depression,
                                                                                          disorganization (negative)
   Wickham et      UK         155     52 %    40.0   RDC2)    Lc 1-4     53          5: depressive, manic, reality
   al. 2001                                                                          distortion, disorganization,
                                                                                          psychomotor poverty
   Serretti and    Italy      1294    45 %    41.7   DSM-IV3)    Lc 1-4     29          5: mania, positive,
   Olgiati 2004                                                                          disorganization,
                                                                                          depression, negative
   Murray et       UK         387     50 %    42.8   ICD-94) and   Lc 1-4     62          4: depression,
   al. 2005                                     ICD-105)                             reality distortion, mania,
                                                                                          disorganization
1) Diagnostic and Statistical Manual of Mental Disorders, Third Edition - Revised (American Psychiatric Association 1987)   
2) Research Diagnostic Criteria (Spitzer et al. 1978)      
3) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (American Psychiatric Association 1994)   
4) International Classification of Diseases, Injuries and Causes of Death, Ninth Edition (World Health Organization 1977)     
5) International Statistical Classification of Diseases and Related Health Problems, Tenth Edition, Diagnostic Criteria for Research. Geneva: World Health Organization 1993)
6) Liability classes: class 1=schizophrenia, class 2=schizoaffective disorder, class 3=schizophreniform, delusional, shared psychotic, and brief psychotic disorder,
 psychotic disorder not otherwise specified, class 4=affective psychotic disorder, class 0=all other mental disorders
7) Major Symptoms of Schizophrenia Scale (Kendler et al. 1994a)    
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4.3.2 Studies based on the Scale for Assessment of Positive and Negative
symptoms of schizophrenia
The  Scale for the  Assessment of  Negative Symptoms (SANS) (Andreasen and Olsen 1982,
Andreasen 1982, 1983) was the first instrument applied to comprehensive assessment of
negative symptoms of schizophrenia. SANS and the Scale for the Assessment of Positive
Symptoms (SAPS) (Andreasen 1984) have been widely used for clarifying the heterogeneity
of the clinical picture in schizophrenia. SANS and SAPS factor analyses have been applied
to "global scores", but there is a risk of missing relationships between individual
symptoms. Here, studies analyzed at item level to achieve a more detailed view of signs
and symptoms of schizophrenia are referred.
Factor analysis of SANS and SAPS since 1993 has resulted in 3-11 factors (Table 2). Malla
et al. (1993) found that the emergence of three factors was not explained by medication.
It was found that the factor symptoms showed familial aggregation (McGrath et al. 2004b)
and that especially the negative symptoms were resistant to cultural influences (Emsley et
al. 2001). Peralta and Cuesta (1999) found 11 symptom factors and suggested that the
factor structure is more complex than assumed.
However, several factor analysis studies of SANS have demonstrated that the structure of
negative symptoms is not one-dimensional (see Table 2 references: Minas et al. 1994,
Peralta and Cuesta 1999). Studies on the factor structure of SANS have found two to five
factors (Mueser et al. 1994, Peralta and Cuesta 1995, Sayers et al. 1996). The precise
number of factors that best represent negative symptoms measured by SANS is unclear;
however, the most reliable factors are diminished expression and a combined anhedonia-
asociality factor (Blanchard and Cohen 2005).
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Table 2. Factor analytic studies based on the Scales for the Assessment of Positive (SAPS) 
and Negative (SANS) Symptoms
Authors    Country Number    Male  Mean Diagnostic  Diagnoses Number and names of the 
and year      of % age  method    factors
of study      subjects  years  Liability
 classes5)
acute/   
chronic  
patients
Malla et      UK     155    76 %  34.2 DSM-III-R2)  Lc 1    3: disorganization, psychomotor poverty,
al. 1993  chronic  reality distortion
Minas et      Australia 114    63 %  27.3 DSM-III1)    Lc 1-4   5: negative signs, social dysfunction,
al. 1994  acute/   delusions, hallucinations,
 chronic  thought disorder
Andreasen et  USA      243    70 %  32.0 DSM-III-R2)  Lc 1, 3  3: positive, disorganized, negative
al. 1995a      chronic
Vazquez-      Spain    86   50 %  15 - PSE4)     Lc 1    4: negative, non-paranoid, paranoid,
Barquero     54    first    disorganized
et al. 1996    episode
Toomey et     USA      549    98 %  49.0 DSM-III-R2)  Lc 1-0   5: diminished expression,
al. 1997      chronic  disorganization, disordered related,
 bizarre delusions,
 auditory hallucinations
Peralta and   Spain    660    54 %  36.0 DSM-III-R2)  Lc 1-4   11: poverty of affect/speech,
Cuesta 1999   acute/   thought disorder/inappropriate affect,
 chronic  bizarre delusions, social dysfunction,
 other delusions, paranoid delusions,
 bizarre behavior, non-auditory
 hallucinations, auditory hallucinations,
 manic thought disorder, attention
Emsley et     South    422    75 %  38.2 DSM-IV3)   Lc 1    5: diminished expression,
al. 2001     Africa    chronic  disordered relating, psychosis,
 thought disorder, bizarre behavior
McGrath et    USA      1043     64 %  39.6 DSM-III-R2)  Lc 1-2   5: positive, negative, disorganized,
al. 2004b    DSM-IV3)     chronic  affective, early onset/developmental
Niehaus et    South    208    81 %  37.8 DSM-IV3)     Lc 1    5: negative, positive, positive thought
al. 2005     Africa   (sibpairs)  chronic  disorder, bizarre behavior, affective
1) Diagnostic and Statistical manual of Mental Disorders, Third Edition (American Psychiatric Association 1980)     
2) Diagnostic and Statistical Manual of Mental Disorders, Third Edition - Revised (American Psychiatric Association 1987)    
3) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (American Psychiatric Association 1994)    
4) Present State Examination, PSE (Wing et al.1974)    
5) Liability classes: class 1=schizophrenia, class 2=schizoaffective disorder, class 3=schizophreniform, delusional, shared psychotic
,
   and brief psychotic disorder, psychotic disorder not otherwise specified; class 4=affective psychotic disorder; class 0=all other mental disorders
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4.3.3 Negative symptoms and family history of schizophrenia
Family history of schizophrenia has been associated with pronounced negative symptoms in
twin (Dworkin and Lenzenweger 1984, Cardno et al. 2001), adoption (Cardno et al. 2002b),
and sibling pair studies (Burke et al. 1996, Hwu et al. 1997, Kendler et al. 1997).
However, two studies (DeLisi et al. 1987, Cardno et al. 1999) reported no significant
concordance in sibling pairs for negative symptoms. Neither did Ritsner and colleagues
(2005), when negative symptoms were assessed using the Positive and Negative Syndrome
Scale (PANSS) and controlled using additional variables like age of onset, baseline
ratings, insight and side effects of medication. However, other studies have found that
negative symptoms associate with the familial form of schizophrenia (Verdoux et al. 1996,
Van Os et al. 1997, Kirkpatrick et al. 2000, Wickham et al. 2001). The deficit form of
schizophrenia, characterized by enduring, primary negative symptoms, has also been
associated with family history of schizophrenia (Malaspina et al. 2000, Ross et al. 2000,
Kirkpatrick et al. 2001).
4.4 Reliability of the schizophrenia diagnosis
4.4.1. Accuracy and reliability of register diagnosis
Access to data from case registers makes it possible to design powerful studies of disease
incidence and prevalence, treatment outcomes and service utilization (Tansella 2000, Byrne
et al. 2005). Byrne and colleagues (2005) assessed the validity of registers used in
psychiatric research in their systematic review. They included fourteen studies, seven of
which concerned Scandinavian registers and five schizophrenia. They were unable to find an
established gold standard for the assessment of register quality. Three studies compared
register data with case notes, testing the reliability of data transfer to the register.
One of these studies concerned the Finnish Hospital Discharge Register (Keskimäki and Aro
1991). The authors assessed the accuracy of 2211 discharges. The accuracy of the principal
diagnosis in the register was 94.6%. However, for schizophrenia the accuracy was 99%, and
subsidiary diagnoses, too, were most accurate in psychiatric hospitals (83%). The
remaining eleven studies assessed case notes to determine a diagnosis, which was then
compared with the register. Several studies reduced researcher subjectivity by employing
operationalized diagnostic criteria. Byrne and colleagues (2005) studied the quality of
these studies by assessing sample number, randomization, blinding (both of the researchers
to each other and to the relevant register data), methods used for assessing validity, and
use of inter-rater reliability. The studies of Isohanni et al. (1997) and Mäkikyrö et al.
(1998) used operationalized DSM-III-R, and the latter also employed OCCPI diagnoses in the
case note review and consensus diagnosis procedure. Study samples were not randomized, but
all cases were included in the Northern Finland 1966 Birth Cohort. Neither inter-rater
reliability nor blinding was stated. Isohanni et al. (1997) found 100% true positive and
48% false negative cases. The sensitivity was 0.52 and specificity 1. Mäkikyrö et al.
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(1998) found 93% positives when schizophrenia, and schizophrenia spectrum disorders were
included. The positive predictive value was 0.87 and the negative 0.82. It has been found
in several studies that Finnish clinicians have a persistent tendency to apply a narrow
definition of schizophrenia, with a tendency to false negative rather than false positive
case diagnoses (Kuusi 1986, Pakaslahti 1987, Salokangas 1997, Isohanni et al. 1997,
Taiminen et al. 2001, Moilanen et al. 2003). Dalman et al. (2002) examined the validity of
the Swedish National Inpatient Register diagnoses of schizophrenia among young cases: 76%
of diagnoses fulfilled the DSM-IV criteria for schizophrenia.
Byrne and colleagues (2005) concluded that despite the widespread use of registers, there
is little empirical literature on their validation and the existing studies vary in
conceptual sophistication and methodology. They emphasized the importance of blindness in
research settings. Statistical methods varied from assessing per centage levels of
agreement between case note and register, to the calculation of specificity and measures
of correlation. The representativeness of the study populations varied too, with most of
the studies concerning inpatient samples.
4.4.2 Reliability of consensus diagnosis
To achieve final best-estimate diagnoses, Leckman et al. 1982 used a sample of 1878
individuals in their methodological study. They formed lifetime psychiatric diagnoses
using direct interviews, family history from multiple informants, and medical records.
They were able to examine the agreement between two raters using a best estimate
diagnostic procedure based on a review of all available information in both interviewed
and non-interviewed samples of patients and their relatives. They concluded that
best-estimate diagnoses were reliable either using interview or all available information
including case notes. McConville and Walker (2000) assessed the reliability of case
register diagnoses, but also the inter-rater reliability of case note diagnoses. They
assessed forty-five randomly selected case notes, and the inter-rater reliability across
all diagnostic categories was kappa=0.71 (p<0.001). Goodman et al. (1984) also assessed
inter-rater reliability and the kappa value was 0.58. Craddock et al. (1996) compared the
OCCPI diagnoses and DSM-III-R plus RDC consensus best-estimate diagnoses in 100 cases.
The agreement between the consensus best-estimate diagnoses was kappa=0.80 for
DSM-III-R and 0.72 for RDC.
4.4.3 Reliability of interview diagnosis
Spitzer et al. (1978) assessed the reliability of Research Diagnostic Criteria (RDC) using
joint interviews, whereby one rater conducted the interview and the other observed. Both
made independent ratings. They also used the test-retest method. For schizophrenia the
kappa in joint interviews was 0.80, and in test-retest 0.65. Skre et al. (1991) assessed
fifty-four audio taped SCID interviews rated independently by three raters. Agreement was
highest (0.93) for schizophrenia and major depressive disorder (0.92). Interrater
reliability was generally good for combinations of two diagnoses, but poorer when three
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were combined. Williams et al. (1992) analyzed 592 subjects with a test-retest method to
calculate the reliability of SCID-III-R interviews. For most of the major lifetime
diagnostic categories the overall weighted kappa was 0.68, for schizophrenia it was 0.68.
Miller (2001) showed that structured interviews like SCID and Computer Assisted Diagnostic
Interview (CADI) (Miller 2001) were significantly more accurate than unstructured
traditional diagnostic assessments for making inpatient diagnoses, using consensus
diagnoses as the golden standard. Fennig et al. (1994) compared best-estimate and
structured SCID-III-R interview diagnoses in a study of first-admission psychosis at entry
and six months later. They concluded that the SCID interview, when administered by closely
supervised experienced non-psychiatrist clinicians and incorporating information from
other sources, can produce reliable diagnoses of schizophrenia and bipolar disorder.
The reliability of SCID-II for personality disorders was tested in 69 patients (Weertman
et al. 2003) and the overall kappa was 0.63. Osone and Takahasi (2003) used the test-
retest reliability assessments for DSM-IV personality disorders. The overall kappa was
0.87. Farmer and Chapman (2002) found in their study of 149 persons that the SCID-II
(DSM-IV) personality questionnaire may perform well as a screening tool for personality
disorder diagnoses. This SCID-II finding suggests generally modest levels of both
comorbidity and covariation across personality disorder concepts. However, the inter-rater
reliability was excellent.
4.5 Summary of the literature
Schizophrenia exists worldwide, its mean prevalence varying around 0.4-0.7% (Saha et al.
2005). However, in isolated populations, the lifetime prevalence has varied from 0.1%
(Chen et al. 1993) to 2.2% (Hovatta et al. 1997).
Both genetic and environmental factors have been shown to be important in the etiology of
schizophrenia. The best documented risk factor related to the development of schizophrenia
is its presence in the family history (Gottesman 1994, McGuffin et al. 1995, Kendler 2000,
Kendler et al. 1993a,b, Varma et al.1997, Chang et al. 2002, Weiser et al. 2005a), in
high risk studies (Cannon and Mednick 1993, Ingraham et al. 1995, Erlenmeyer-Kimling et
al. 1997, Niemi et al. 2004), in twin studies (Cannon et al. 1998, Sullivan et al. 2003)
and in adoption studies (Kendler and Gruenberg 1984, Kety et al. 1994, Tienari
et al. 2000, 2003).
The signs and symptoms of schizophrenia are complex, encompassing almost every aspect of
cognition and behavior. Unfortunately, we have no laboratory or other objective tests to
diagnose schizophrenia and thus accurate observation and recording of signs and symptoms
is generally the only way of forming a reliable diagnosis. However, the phenotype of
schizophrenia is heterogeneous and several studies have attempted to divide it into
subtypes or dimensions to identify risk factors. Recently the symptoms and signs of
schizophrenia and psychotic disorders have been divided into four or five dimensions:
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positive, disorganization, negative, and two affective dimensions: mania and depression
(McGrath et al. 2004b, Serretti and Olgiati 2004, Murray et al. 2005, Niehaus et al.
2005).
Several studies have found that negative symptoms associate with the familial form of
schizophrenia in twin (Dworkin and Lenzenweger 1984, Cardno et al. 2001), adoption (Cardno
et al. 2002b), and sibling pair studies (Burke et al. 1996, Hwu et al. 1997, Kendler et
al. 1997) and other studies (Verdoux et al. 1996, Van Os et al. 1997, Kirkpatrick et al.
2000, Wickham et al. 2001). The deficit form of schizophrenia, characterized by enduring,
primary negative symptoms, has also been associated with family history of schizophrenia
(Malaspina et al. 2000, Ross et al. 2000, Kirkpatrick et al. 2001).
Accurate diagnoses are essential for genetic studies of schizophrenia. However, the
literature on register data validation for research is sparse (Byrne et al. 2005). It has
also been found in several studies that Finnish clinicians have a persistent tendency to
apply a narrow definition of schizophrenia, with a tendency to false negative rather than
false positive case diagnoses (Kuusi 1986, Pakaslahti 1987, Salokangas 1997, Isohanni et
al. 1997, Taiminen et al. 2001, Moilanen et al. 2003).
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5. AIMS OF THE STUDY
The present investigation forms part of the study "The Genetic Epidemiology and Molecular
Genetics of Schizophrenia in Finland", which was initiated in 1988 at the National Public
Health Institute’s Department of Mental Health and Alcohol Research in collaboration with
the Department of Molecular Medicine. The general aim of this study was to identify
clinical phenotypes of schizophrenia for molecular genetic studies in isolate families
representing a homogeneous population with high prevalence of schizophrenia.
The specific aims of the present thesis were:
I.    To  reassess  the  register-,  case  record- and  interview-based  lifetime  prevalence
      of  schizophrenia  and  schizophrenia  spectrum or  associated  psychotic disorders,
      the  cumulative  incidence  and  reliability  of  the   schizophrenia  diagnoses  in   a
      genetically homogeneous isolate birth cohort born between 1940 and 1969.
II.   To  examine  using  Operational  Criteria  Checklist  for  Psychotic Illness  (OCCPI)
      factor  analysis  the  psychotic and  affective  signs  and  symptoms of schizophrenia
      in  the  genetically   homogeneous  isolate   population,  and  to  compare the  factor
      solutions   in    the    isolate    and   among   individuals   with   schizophrenia   from
      multiplex families identified from the whole country.
III.  To examine using the Scales for the Assessment of Negative and Positive Symptoms
      (SANS and SAPS)    the  signs  and  symptoms  of    schizophrenia  in  a  genetically
      homogeneous  isolate  and a  nationwide  multiplex family sample, and to investigate
      the symptom dimensions and their association with the degree of familial loading for
      psychotic disorders and with consanguinity.
IV.   To investigate whether siblings of patients with schizophrenia can be identified as not
      having any psychotic disorder using health care  register information only, to analyze
      the  emergence of psychotic disorders  among siblings of  patients with schizophrenia
      during seven to 11 years of follow-up, and to compare the  prevalence  of  psychiatric
      disorders between siblings of  patients  with  schizophrenia  and a  random population
      sample.
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6. SUBJECTS AND METHODS
6.1 Identification of the isolate and families from the isolate
and the whole country
6.1.1 Identification of the isolate
The project was initiated in 1988, and subsequently the research and sample collection for
genetic studies was started in 1991. Kuusamo (population 17000) was known to have a high
prevalence of schizophrenia and a population history of isolation excellent for genetic
studies. The principal investigators of the project were Professor Jouko Lönnqvist and
Professor Leena Palotie. The study protocol was approved by the Ethics Committee of the
National Public Health Institute, and by the Ministry of Social Affairs and Health.
The population history of Finland and this isolate is well known: multiple bottlenecks and
36 monogenic diseases have been identified as enriched in the Finnish population (Peltonen
et al. 1999, Varilo and Peltonen 2004). The expansion of the Finnish population was based
on agriculture and animal husbandry thought to have been introduced by eastern Uralic
speakers 4000 years ago and settlers from the south 2000 years ago. Since then, Finland
has been relatively isolated for geographic, linguistic and cultural reasons (Nevanlinna
1972, Peltonen et al. 1999). The northern and eastern parts of the country were settled
from the south relatively recently, in the 16th and 17th centuries.
The study isolate was genetically formed in north-eastern Finland by only 39 families
during this late settlement, and it remained almost completely isolated by distance until
the 1940s (Varilo et al. 2003). In 1940-1960 there was substantial emigration to Sweden,
although the population remained stable (Korkiasaari 1989). The inhabitation of the
isolate is documented since 1676, and precise details of all births, deaths, marriages and
movements have been found from the exceptionally well kept local church records (Hovatta
et al. 1997, Varilo et al. 2003).
The isolate developed from a rural municipality in the 1940s and has a present population
of about 17000. However, there are still only 3.5 inhabitants per square kilometer (see
municipal data at http://www.kuusamo.fi). Kuusamo also has a simple service system: one
health care center with a hospital closely associated with the university hospital in
Oulu, north-western Finland.
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6.1.2 Identification of isolate and multiplex families from the whole
country
First, we utilized three nationwide health care registers to identify all schizophrenia
patients with a diagnosis of schizophrenia, schizoaffective or schizophreniform disorder
in at least one of the registers who were born from 1940 to 1969. Later we widened the
Hospital Discharge Register data to patients born 1940-1976 and updated the Hospital
Discharge Register information from 1991 to 1998. We identified altogether 33731 patients
from the Finnish Hospital Discharge Register, the Disability Pension Register, and the
Free Medicine Register (Figures 1 and 2).
We identified the first-degree relatives for each patient from the National Population
Register, which was created in 1969 using local church registers and verified in 1973.
Personal identification codes for every citizen were introduced earlier, in 1964. However,
the family information was not found for 6079 patients and they were excluded. Over 80% of
excluded patients were born from 1940 to 1949.
The total number of isolate patients in 1998 was 658, in 379 families. The total number of
isolate patients is summarized in Figure 2. The inclusion and exclusion criteria varied in
studies I-IV. In Study I we identified isolate birth cohorts, but in Studies II-IV we
identified patients who had at least one parent born in the isolate. It took several years
to collect the whole sample (Figure 1). Study II was done first, so we had register data
only until 1991 and had not assessed all consensus diagnosis.
In the final isolate sample (Figure 2) we collected blood samples from 331 patients: 167
(25%) refused and 24 patients were not found. The studies by the Department of Molecular
Medicine at the Public Health Institute have been reported in detail previously (Hovatta
et al. 1997, 1998, 1999, Ekelund et al. 2000, 2001, 2004, Hennah et al. 2003, Paunio et al.
2001, 2004, Varilo et al. 2000, Varilo and Peltonen 2004). All patients and relatives gave
their written informed consent, and the collection of blood samples was carried out as
recommended in the Helsinki Declaration and amentments.
We reassessed the register diagnoses of 326 patients who participated in the genetic
study. However, five patients remained without a consensus diagnoses because of
insufficient or missing case records. A further 49 (15%) refused the interview and
neuropsychological test, and a total of 257 patients participated in all analyses till
2002 (Figure 2). Their cognitive performance was assessed with a battery of
neuropsychological tests (Tuulio-Henriksson et al. 2002, 2003, 2004, Paunio et al. 2004).
156 (24%) of 658 patients were deceased by 2002, concordant with the rate in a study of
long-stay psychiatric patients in northern Finland (Räsänen et al. 2003).
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Figure 1. Clinical examinations and diagnostic procedures
                               I Registers: 1969-1991 (1998)
                               Hospital Discharge
                               Disability Pension
                               Free Medicine (1969-1985)
                               National Population
ISOLATE FAMILIES                                       WHOLE COUNTRY FAMILIES
   At least one parent born in                             At least two affected siblings
   the isolate.                                            in the family.
   Patients born 1940-76 with                              Patients born 1940-76 with
   a diagnosis of schizophrenia,                           a diagnosis of schizophrenia,
   schizoaffective or                                      schizoaffective or
   schizophreniform disorder                               schizophreniform disorder
   (code 295)1)                                            (code 295)1)
II Blood samples 1991-2002                             II Blood samples 1991-2002
Genealogical research            
III Case records:                                       III Case records: 
Consensus diagnoses2) and  Consensus diagnoses2) and
OCCPI3 ratings                                          OCCPI3) ratings
   1995-2002                                               1995-2002
IV Clinical interviews:                                 IV Clinical interviews:
                                                           Random sample
SCID4), SANS5), SAPS6)  SCID4), SANS5), SAPS6)
   Neuropsychological tests                                Neuropsychological tests
   1998-2002                                               1998-2002
1) Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death, 8th Edition and 9th Edition
(World Health Organization 1967, 1977, American Psychiatric Association 1987)
2) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (American Psychiatric Association 1994)
3) Operational Criteria Checklist for Psychotic Illness (McGuffin et al. 1991)
4) Structured Clinical Interview I and II for DSM-IV (First et al. 1996, 1997)
5) Scale for the Assessment of Negative Symptoms (Andreasen 1983)
6) Scale for the Assessment of Positive Symptoms (Andreasen 1984)
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Figure 2. Conclusion of identification of schizophrenia patients in the isolate born 1940-76 
     Disability Pension             Free Medicine                  Hospital Discharge
     Register N=20096               Register N=19487               Register N=25882
                             33731 patients with a diagnosis of
                             schizophrenia, schizoaffective- or
                             schizophreniform disorder in at
                             least one of the registers
                                                                     6079 patients were exluded:
                                                                     no family information
                             National Population Register
                             27652 patients had family
                             information
ISOLATE PATIENTS
                             379 families
                             658 patients
                                                                     136 deceased, 167 refused,
                                                                     24 not found
                             Blood sample 331 patients
                             Genealogical research 263 families
                                                                     No consensus 5 patients
                             326 patients (246 schizophrenia)
                             DSM-IV1) reassessed consensus
                             diagnoses OCCPI2) ratings and
                             diagnoses
                      
                                                                     49 refused, 20 deceased
                             257 patients (217 schizophrenia)
                             with SCID-I-II3), SANS4) and
                             SAPS5) interviews
1) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (American Psychiatric Association 1994)
2) Operational Criteria Checklist for Psychotic Illness (McGuffin et al. 1991)
3) Structured Clinical Interview I and II for DSM-IV (First et al. 1996, 1997)
4) Scale for the Assessment of Negative Symptoms (Andreasen 1983)
5) Scale for the Assessment of Positive Symptoms (Andreasen 1984)
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We  also  identified  a  total of  4904  whole  country  multiplex  family patients with at least
two affected siblings using the same registers. The study protocol was similar to that for
the isolate sample (Figure 1), and we collected 1167 blood samples and made 945 consensus
diagnoses and Operational Criteria Checklist for Psychotic Illness (McGuffin et al. 1991)
(OCCPI) ratings. We then chose a random sample of 138 multiplex families from the whole
country. We contacted 661 individuals, of whom 140 refused (21%) the interview and
neuropsychological tests. Ninety-four of the interviewed patients had a consensus
diagnosis of schizophrenia and were included in Study III.
6.2 Subjects in Studies I-IV
6.2.1 Subjects in Study I
We utilized the register information to identify all persons in the isolate born in the
1940-1969 birth cohorts, who had been hospitalized with a diagnosis of schizophrenia
(295.0-3, 5-6, 8-9), schizoaffective (295.7) or schizophreniform (295.4) disorder,
between 1 January 1969 and 31 December 1998. Code 295 refers here to these three disorders
identified from the registers. We also used the Disability Pension Register until 1991 and
the Free Medicine Register until 1986 to identify schizophrenia patients who had not been
hospitalized (N=17). Of the 282 patients identified, 45 (16%) patients had died before
1998, leaving 237 patients to be included in our study.
Seventy-three of 237 patients did not receive a consensus diagnosis: 51 of them had not
been willing to participate in the genetic study and 22 did not have a parent born in the
isolate and were not included in the genetic study. We then contacted all 164 patients
born in the isolate and with at least one parent also born in the isolate, who had a
consensus diagnosis and had participated in our genetic studies of patients. We
interviewed 131 of these patients, as six had deceased, 23 patients refused, and in four
cases the doctor or nurse in charge of the patient’s care denied contact.
The corresponding birth cohorts of the isolate from 1940 to 1969 (N=14817), who were
living in whole Finland and alive in 1998 (N=12368) were identified from the National
Population Register, as were the number of deaths from 1940 to 1998 in the birth cohorts.
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6.2.2 Subjects in Study II
For this study we included patients identified from the registers in 1991 who had a
consensus diagnosis up to October 1, 2000. Patients were born from 1940 to 1969 and had a
register diagnosis of schizophrenia (code 295), and at least one parent born in the
isolate. We also included 28 extra families in the isolate study from a neighbouring
municipality - previously part of Kuusamo and with a similar inhabitation history. In
addition, four other families were identified by local doctors from the Kuusamo health
center. In total there were 397 families and 588 patients. The 588 patients included 523
siblings, 38 mothers, 21 fathers and three families where both parents were affected. We
collected and made consensus diagnoses and OCCPI ratings for 306 isolate patients and
family members. 190 patients had a consensus diagnosis of schizophrenia in October 2000.
Further, among these 190 patients with a consensus diagnosis we had 112 isolate singleton
patients who were the only affected individuals in their family, and 78 isolate multiplex
patients.
Schizophrenia multiplex families from the whole country with at least two affected
siblings born between 1940 and 1969 were also identified to represent familial
schizophrenia; there were 2239 families with 4904 patients. They were identified from the
registers using the same protocol as for the isolate patients. The inclusion criteria for
diagnosis were schizophrenia, and schizoaffective or schizophreniform disorder (code 295).
We collected blood samples and made OCCPI ratings and consensus diagnoses reassessment
using the same study protocol as in the isolate study (Figure 1). We had made 466 OCCPI
ratings and consensus diagnoses of schizophrenia up till 1 October 2000 in the families
from the whole country.
6.2.3 Subjects in Study III
In Study III we could identify more isolate patients than in Study II. Patients were born
from 1940 to 1976 and we also had Hospital Discharge Register data from 1969 to 1998, i.e.
seven years more compared to Study II. However, we did not include those 28 families from
the neighbouring municipality.
The whole country multiplex patients were identified using the same health care registers
as in the isolate study, but they had two or more affected siblings in the family (code
295). We identified for interviews a random sample of 138 families from the 4904 multiplex
families in the whole country. We contacted 661 individuals and 140 refused (21%).
Ninety-four interviewed patients had a consensus diagnosis of schizophrenia and were
included in Study III.
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Our final representative Study III sample contained 290 interviewed patients with a
consensus diagnosis of schizophrenia. We divided them into three groups: 196 patients from
the isolate, comprising 63 multiplex family patients and 133 isolate singleton patients,
plus 94 multiplex family patients from the whole country. The criteria for multiplex
patients were as follows: (1) at least one interviewed sibling with a DSM-IV (Diagnostic
and Statistical Manual of Mental Disorders, American Psychiatric Association 1994)
consensus diagnosis of schizophrenia (schizoaffective or schizophreniform disorder not
included), and (2) at least one sibling with a diagnosis of schizophrenia or other
psychotic disorder in registers or by consensus diagnosis. The interviewed singleton
patients had no first-degree relatives with any psychotic disorder.
In addition, we linked the genealogical information from the isolate pedigrees to
phenotype information and DSM-IV consensus diagnoses. To estimate the degree of
familiality with each patient, we counted consanguineous patients through all common
founders in four-generation pedigrees. We included the consanguineous patients from 263
families born 1940 to 1976, based on the liability classes of DSM-IV diagnoses (Figure 3).
The genealogical research was conducted at the Department of Molecular Medicine. The
ancestors of the schizophrenia patients in the isolate were traced back four to 12
generations and large four-generation pedigrees were constructed in accordance with
published criteria (Figure 3)(Varilo et al. 1996, Hovatta et al. 1999, Varilo et al. 2003).
Figure 3. A large four-generation pedigree of families with schizophrenia in the isolate.
              (next page)
Affected individuals of 263 families are in black. DSM-IV consensus diagnoses are shown in liability classes:
class 1= schizophrenia, class 2= schizoaffective disorders, class 3= schizophreniform, delusional, shared psychotic
and brief psychotic disorder, and psychotic disorder not otherwise specified, class 4= affective psychotic disorder,
class 0= all other mental disorders.
    = female, = male, = affected female, = affected male, = multiple affected siblings.
LC= liability class of the youngest generation is marked below the pedigree, S= spouse with the respective number
drawn  elsewhere  in the  pedigree,   Plain numbers= the  number of  affected  offspring  born  1940-76 of a  given
ancestral couple.
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6.2.4 Subjects in Study IV
We followed-up siblings of schizophrenia patients in the isolate using the original
register data from 1991 with 365 isolate families. These 365 isolate families had 446
patients born from 1940 to 1969, as in the Study II. However, the numbers are different
because we did not include patients from the neighbouring municipality in the study. We
contacted the patients and first-degree relatives from 1998 to 2002 and interviewed them
using the Structured Clinical Interview for DSM-IV (SCID-I-II) (First et al. 1996, 1997),
and the Scales for the Assessment of Negative Symptoms (SANS) and Positive Symptoms
(SAPS) (Andreasen 1983, 1984).
For those 446 patients (code 295) identified in the isolate we identified a total of 1353
healthy isolate siblings born from 1940 to 1969 without a register diagnosis of psychosis
(Figure 4). Information on the siblings was linked back to the health care registers to
obtain data on their hospital admissions, pensions, and free medications. Of the total of
1353 healthy siblings, 280 were dead. 158 (18%) refused, 458 were not contacted, and in 78
cases we could not find the treating person for the affected sibling. Of the 379 initially
healthy siblings who gave a blood sample, 248 were interviewed and tested. Ten were
deceased and 53 (17%) refused, and three patients did not give permission to contact their
five siblings. Because of time and budgetary limitations we could not interview the 63
initially healthy siblings who had participated in the genetic studies (Figure 4).
Although we could not contact all healthy siblings, for every patient we aimed to
interview and test at least one sibling close in age (Tuulio-Henriksson et al. 2003). This
age criterion was set because we wanted to minimize age-related differences in
neuropsychological performance between siblings.
The inclusion criteria for a patient were based on an interview diagnosis of schizophrenia
or schizoaffective disorder, as well as fulfillment of the condition that the patient had
a sibling without register diagnosis of psychosis and who was interviewed. 183 patients
received a SCID interview diagnosis of schizophrenia or schizoaffective disorder. However,
59 patients were without an interviewed initially healthy sibling born from 1940 to 1969.
In the end, therefore, we had 124 patients and 183 initially healthy siblings in 110
families.
Besides interviews, we also obtained information from the Finnish Hospital Discharge
Register on all hospital treatments for mental disorders between 1991 and 1998 for both
patients and siblings.
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Figure 4.  Identification of initially healthy siblings (study IV)
     Isolate patients (N=446) (born 1940-69) with register1) diagnosis of schizophrenia,
     schizoaffective or schizophreniform disorder (code 295)
     1353 siblings (born 1940-69) without diagnosis of psychotic disorder in registers1)
                                                         in 1991
                                                        280 deceased
                                                        158 refused
                                                        78 not contacted because the
                                                        person treating affected
                                                        siblings was not found
                                                        458 not collected
379 blood samples
                                                        10 deceased
                                                        53 refused
                                                        For 5 siblings of 3 affected
                                                        siblings no permission given
                                                        for interview
                                                        63 not collected
                       248 initially healthy siblings were
                       interviewed2) and received
                       neuropsychological tests
                       183 initially healthy siblings
                       of 124 patients with interview
                       diagnosis2) of schizophrenia or
                       schizoaffective disorder in
                       110 families were included in the
                       study
1) Registers: Hospital Discharge 1969-1991, Disability Pension 1969-1991, Free Medicine 1969-1985
2) Structured Clinical Interview I and II for DSM-IV (First et al. 1996, 1997)    
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6.2.4.1 Comparison group (Study IV)
The  comparison   group  (N=111)  was   a   representative   sample   of  the  Finnish  general
population aged 30-79. The sample was identified from the Health 2000 Survey, which is
based on a nationally representative two-stage cluster sample of 8028 persons aged 30 or
over (Aromaa and Koskinen 2004). Of the 161 subjects randomly selected from those who had
participated in any of the study phases, 111 (69%) were interviewed with SCID-I during
2002-2004 and were taken as the comparison group for this study. Information on hospital
treatments from 1974 to 2002 for any psychotic disorders was collected from the Hospital
Discharge Register.
6.3 The Finnish Health Care Registers from 1969 to 1998
The Finnish Hospital Discharge Register covers all mental and general hospitals, as well
as in-patient wards of local health centers, military wards, prison hospitals and private
hospitals. It was computerized in 1968. We identified all patients who had been
hospitalized between 1 January 1969 and 31 December 1991 (register codes 295.0-9),
and later until 1998 (register codes F20.0-9, F23.1-2, F25.0-9). We also had
Register data from two Social Insurance Institution Registers, namely the Disability
Pension and the Free Medicine Registers. From the Disability Pension Register we collected
data until December 1991; this register codes only the first three digits (295) of the
diagnostic codes. The Free Medicine Register had its own code 12 for schizophrenia
patients until the end of 1985, so we included patients according to this information
from 1969 to 1985. The Hospital Discharge Register data consist of admission and discharge
dates, primary and subsidiary diagnoses, and hospital identification codes for each
inpatient. The Pension Register records the starting and ending dates and the primary
diagnoses for disability pensions. The Free Medicine Register indexes the diagnoses of
persons receiving state-subsidized outpatient medication. We used the unique personal
identification numbers to link the data in these registers to the National Population
Register, which has information on place of birth, date of death, place of current
residence, marital status, and first-degree relatives of each Finnish citizen. The
National Population Register was created in 1969 and updated in 1973 with family
information, so the complete data on first-degree relatives can be found from 1973 for
people born in the 1950s and later.
The diagnostic criteria of schizophrenia varied during the period 1969 to 1998 when the
Hospital Discharge, Disability Pension and Free Medicine Registers were used for our study
data. The criteria of schizophrenia used in Finland are presented in following sections.
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6.3.1 International Classification of Diseases, Eighth Edition
The Manual of the International Statistical Classification of Diseases, Injuries and
Causes of Death, 8th Edition (ICD-8) (World Health Organization, 1967) provided no
criteria for schizophrenia, but the ICD-8 glossary characterized the subtypes of
schizophrenia. The simple type had oddities of conduct, difficulties in social contact,
and decline in overall performance but without clear-cut positive symptoms of
schizophrenia. The hebephrenic type had inappropriate affect, behavior often silly and
empty of purpose and feeling, and prominent thought disorder. The catatonic type was
characterized by catatonic symptoms, and the paranoid type by prominent delusions and
hallucinations. The latent type was characterized by the emergence of symptoms not
obviously schizophrenic but severe enough to raise a strong suspicion of schizophrenia.
The residual type was characterized by a chronic residual state in which fragments of
faded schizophrenic symptomatology occurred. Other and unspecified types did not fit into
these subtypes. Acute schizophrenic episode was characterized by acute onset of
schizophrenic symptoms often presenting as a dream-like state with slight clouding of
consciousness and perplexity. The schizo-affective type included cases where both the
affective and schizophrenic symptoms were pronounced. Infantile autism was also regarded
as a part of schizophrenia. So the definition for schizophrenia was broad and based on the
severity of social and personal dysfunction. There was also considerable overlap with
personality disorders.
6.3.2 International Classification of Diseases, Ninth Edition
In the ninth edition of ICD (ICD-9) (World Health Organization, 1977, 1978) the childhood
type of schizophrenia and infantile autism were removed from schizophrenic psychoses, but
simple and latent schizophrenia remained. In Finland, however, the first four numbers in
the diagnostic codes corresponded to the ICD-9 codes. We used the narrower DSM-III-R
criteria and the fifth digit was similar to the third revised Diagnostic and Statistical
Manual of Mental Disorders (DSM-III-R) (American Psychiatric Association, 1987). However,
the schizophreniform and schizoaffective disorders were still classified as schizophrenic
psychoses, as in the ICD-8 and ICD-9.
6.3.3 International Classification of Diseases, Tenth Edition
The tenth edition of ICD (ICD-10) (World Health Organization, 1993) and its diagnostic
codes and criteria have been used in Finland since 1996. Its diagnostic criteria of
schizophrenia differ from those of the DSM-IV. The DSM-III-R (American Psychiatric
Association, 1987) and the DSM-IV (American Psychiatric Association, 1994) require a six
month duration of symptoms vs. only one month for ICD-10, and ICD-10 does not require
deterioration from a premorbid level of functioning, whereas DSM-III-R and IV do. ICD-10
also has an exclusion criterion for mood disorder before the onset of schizophrenia, while
DSM-IV requires that the total duration of all episodes of a mood syndrome has been brief
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relative to the total duration of the active and residual phases of the disturbance. The
ICD-10 diagnostic classification included negative symptoms prior to the publication of
DSM-IV. Latent schizophrenia has now been removed from ICD-10 and nowadays patients
having it might be classified with schizotypal personality disorder.
6.4 The research diagnosis of schizophrenia
In our study we used the DSM-IV criteria both in case record based consensus diagnosis
assessments and in interviews. When we assessed interview based diagnoses, we used the
Structured Clinical Interviews for DSM-IV: Structured Clinical Interview for DSM-IV Axis I
Disorders, Clinician Version (SCID-CV) (First et al. 1996) and Structured Clinical
Interview for DSM-IV Personality Disorders, (SCID-II) (First et al. 1997) based
assessments.
The DSM-IV is a classification of mental disorders developed for use in clinical,
educational and research settings. It is a multiaxial system with five axes: I Clinical
disorders and other conditions that may be a focus of clinical attention, II Personality
disorders and mental retardation, III General medical conditions, IV Psychosocial and
environmental problems, and V Global assessment of functioning (GAF). The five axes may
help the clinician plan treatment and predict outcome, and it also facilitates
comprehensive and systematic evaluation. The text of DSM-IV systematically describes each
disorder: diagnostic features, subtypes and/or specifiers, recording procedures,
associated features and disorders, specific culture, age and gender features, prevalence,
course, familial pattern, and differential diagnosis.
SCID-I (First et al. 1996) and SCID-II (First et al. 1997) are semistructured interviews
for DSM-IV diagnosis and have a one-time-use scoresheet containing DSM-IV diagnostic
criteria and interview questions plus the GAF assessment scale. The majority of questions
can be answered by a simple "yes" or "no"; however it is usually necessary to ask the
patient to elaborate or provide specific examples. The clinician version covers only those
DSM-IV diagnoses most commonly seen in clinical practice. It contains an overview and six
modules: mood episodes, psychotic symptoms, psychotic disorders, mood disorders, substance
use disorders, and anxiety and other disorders.
SCID-II covers all axis II personality disorders. In the interview the subject first
filled out the personality questionnaire as a screening tool. In our study, for all items
with a "yes" answer on the questionnaire the interviewer continued to ask all questions
concerning that specific personality disorder.
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6.4.1 The DSM-IV criteria for schizophrenia
The DSM-IV criteria for schizophrenia are shown in Table 3. DSM-IV divides schizophrenia
further into five subtypes on the following algorithm: catatonic type is assigned whenever
prominent catatonic symptoms are present (regardless of the presence of other symptoms);
disorganized type is assigned whenever disorganized speech and behavior, and flat or
inappropriate affect are prominent (unless catatonic type is also present); paranoid type
is assigned whenever there is a preoccupation with delusions or frequent hallucinations
are prominent (unless the catatonic or disorganized type is present). Undifferentiated
type is a residual category describing presentations that include prominent active-phase
symptoms not meeting criteria for the catatonic, disorganized, or paranoid type; and
residual type is for presentations in which there is continuing evidence of the
disturbance, but the criteria for the active-phase symptoms are no longer met.
Schizophreniform disorder has identical features to schizophrenia except for two
differences: the total duration of the illness is at least one month but less than six
months (See Table 3, criterion C), and impaired social or occupational functioning during
some part of the illness is not required (See Table 3, criterion B). The specifiers: with
good prognostic features or without good prognostic features, may be used to indicate the
presence or absence of features that may be associated with a better prognosis.
The essential feature of schizoaffective disorder is an uninterrupted period of major
depressive, manic, or mixed episode concurrent with symptoms that meet criterion A (See
Table 3) for schizophrenia. In addition, during the same period of illness, there have
been delusions or hallucinations for at least two weeks in the absence of prominent mood
symptoms. The mood symptoms are also present for a substantial portion of the total
duration of the illness. There are two subtypes: bipolar type, and depressive type - which
includes only major depressive episodes.
In our study, we divided the diagnosis into six liability classes: class 1, schizophrenia;
class 2, schizoaffective disorder; class 3, schizophreniform, delusional, shared
psychotic, and brief psychotic disorder, and psychotic disorder not otherwise specified;
class 4, affective psychotic disorder; class 5, organic psychotic disorders; and class 0,
all other mental disorders.
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Table 3. Diagnostic criteria for Schizophrenia (DSM-IV)
A. Characteristic symptoms: Two (or more) of the following, each present for a significant
   portion of time during a 1month period (or less if successfully treated):
             (1)  delusions
             (2)  hallucinations
             (3)  disorganized speech (e.g. frequent derailment or incoherence)
             (4)  grossly disorganized or catatonic behavior
             (5)  negative symptoms, i.e., affective flattening, alogia, or avolition
             note: Only one Criterion A symptom is required if delusions are bizarre or hallucinations
             consist of a voice keeping up a running commentary on the person’s behavior or
             thoughts, or two or more voices conversing with each other.
B. Social/occupational dysfunction: For a significant portion of the time since the onset
   of the disturbance, one or more major areas of functioning such as work, interpersonal
   relations, or self-care are markedly below the level achieved prior to the onset (or when
   the onset is in childhood or adolescence, failure to achieve expected level of
   interpersonal, academic, or occupational achievement).
C. Duration: Continuous signs of the disturbance persist for at least 6 months. This
   6-month period must include at least 1 month of symptoms (or less if successfully treated)
   that meet Criterion A (i.e., active-phase symptoms) and may include periods of prodromal
   or residual symptoms. During these prodromal or residual periods, the signs of the
   disturbance may be manifested by only negative symptoms or two or more symptoms listed in
   Criterion A present in an attenuated from (e.g. odd beliefs, unusual perceptual
   experiences).
D. Schizoaffective and mood disorder exclusion: Schizoaffective disorder and mood disorder
   with psychotic features have been ruled out because either (1) no major depressive, manic
   or mixed episodes have occurred concurrently with the active-phase symptoms; or (2) if
   mood episodes have occurred during active-phase symptoms, their total duration has been
   brief relative to the duration of the active and residual periods.
E. Substance/general medical condition exclusion: The disturbance is not due to the direct
   physiological effects of a substance (e.g., a drug of abuse, a medication) or a general
   medical condition.
F. Relationship to a pervasive developmental disorder: If there is a history of autistic
   disorder or another pervasive developmental disorder, the additional diagnosis of
   schizophrenia is made only if prominent delusions or hallucinations are also present for
   at least a month (or less if successfully treated).
Classification of longitudinal course (can be applied only after at least 1 year has
elapsed since the initial onset of active-phase symptoms):
Episodic With Interepisode Residual Symptoms (episodes are defined by the reemergence of
prominent psychotic symptoms); also specify if: With Prominent Negative Symptoms
Episodic With No Interepisode Residual Symptoms
Continuous (prominent psychotic symptoms are present throughout the period of
observation); also specify if: With prominent Negative Symptoms
Single Episode in Partial Remission: also specify if: With Prominent Negative Symptoms
Single episode In Full Remission
Other or Unspecified Pattern
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6.5. Case record based assessments
6.5.1. The Consensus diagnoses
We  collected  original  case  notes  from  the  psychiatric   hospitals   based  on  data  in  the
Hospital Discharge Register, which records all hospital treatments in Finland. The case
notes from outpatient services were collected from Kuusamo outpatient service and the
health care center. We also used hospital case records to identify outpatient services if
the patient was living outside Kuusamo. If the hospital case notes were missing or
insufficient we collected case notes from the municipalities where the patient had been
living.
The mean follow-up time was 16.6 (SD 5.4) years from the first hospitalization until 1
October 2000 (Study II). However, the last consensus diagnoses were made in 2002. We
validated and re-assessed the diagnoses of all patients and family members who
participated in the genetic studies. Two researchers independently made best-estimate
diagnoses using DSM-IV criteria (American Psychiatric Association 1994). Although they
were blind to the register diagnoses, they knew the study protocol and could not be
completely blind. In cases of disagreement, a third senior researcher reviewed the case to
achieve the consensus diagnosis.
The consensus diagnoses for the isolate cases were made by the author with two other
researchers. Altogether we made 406 consensus diagnoses including patients and first-
degree relatives. For the multiplex families from the whole country the consensus
diagnoses (N=945) were made in the same way by six researchers. In the isolate, the kappa
values for the DSM-IV best-estimate diagnoses of schizophrenia were 0.95 (95% CI
0.84-1.0), for schizoaffective disorder 0.94 (95% CI 0.83-1.0), and for schizophreniform
disorder 0.97 (95% CI 0.85-1.0). In the whole country multiplex family sample the kappa
values were 0.85 (95% CI 0.79-0.92) for schizophrenia, and 0.73 (95% CI 0.60-0.85) for
schizoaffective disorder and schizophrenia spectrum (schizoid, schizotypal and paranoid
personality disorders, schizophreniform, delusional, and brief psychotic disorders and
psychotic disorder NOS) (Ekelund et al. 2000). The consensus diagnoses were used as
inclusion criteria: in Studies II and III we included all patients with a consensus
diagnosis of schizophrenia, while in Study IV both schizophrenia and schizoaffective
disorder were inclusion criteria. In Study I we assessed the reliability of consensus,
register, and interview diagnoses.
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6.5.2. The Operational Criteria Checklist for Psychotic Illness ratings
The Operational Criteria Checklist for Psychotic Illness 3.31 (OCCPI) was originally
designed to facilitate a polydiagnostic approach to the diagnosis of psychotic and
affective disorder for molecular genetic research. However, it has been used in a wide
variety of clinical, epidemiological and biological research.
The OCCPI comprises a 90-item checklist of signs and symptoms and a suite of computer
programs (OPCRIT)(Appendix 1). It has a glossary of clear and explicit descriptions of
each constituent item and instructions for coding them. It generates diagnoses based on 12
different operational diagnostic systems including the 1) DSM-III (American Psychiatric
Association 1980), 2) DSM-III-R (American Psychiatric Association 1987), 3) ICD-10 (World
Health Organization 1993), 4) St. Louis criteria (Feigner et al. 1972), 5) Research
Diagnostic Criteria (RDC) (Spitzer et al. 1978), and 6) Taylor and Abrams criteria (Taylor
and Abrams 1978). The OCCPI also allows the diagnosis of schizophrenia to be made
according to the 7) "flexible" criteria for schizophrenia of Carpenter (Carpenter et al.
1973), and 8) Schneider’s first-rank symptoms (Schneider 1959), and 9-11) according to
three sub-typing classifications of schizophrenia (Tsuang and Winokur 1974, Crow 1980,
Farmer et al. 1983), and 12) a version of the French criteria for non-affective psychosis
(Pull et al. 1987). Farmer and colleagues (1992) compared these diagnoses and concluded
that skilled clinical judgment remains the most reliable and valid tool the researcher
possesses. In this study we used the case record-based DSM-IV consensus diagnoses in our
analysis, not the operational diagnoses of OCCPI. In study II we analyzed by factor
analysis the item level information on the OCCPI (Appendix 1).
The reliability of the OCCPI has been demonstrated in many studies (McGuffin et al. 1991,
Craddock et al. 1996, Williams et al. 1996, Azevedo et al. 1999). Item-by-item agreement
has been measured in only a few studies and the agreements between raters have been
reasonable (McGuffin et al. 1991, Cardno et al. 2001).
To assess the diagnostic agreement, three psychiatrists independently made the OCCPI
DSM-III-R diagnoses and the DSM-IV best-estimate diagnoses from the lifetime case notes
for a random sample of 30 representative cases. All the OCCPI and DSM-III-R diagnoses were
the same, and only one case note diagnosis was assessed in liability class 2 instead of
class 1 by one of the researchers. The OCCPI item-by-item agreement was less good,
however, as also in the study of Cardno and colleagues (2001). In our study the kappa
values varied from 0.10 to 0.84. For the OCCPI factor analysis we chose 30 psychotic and
affective items with kappa values exceeding 0.46.
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6.6. Clinical interviews
6.6.1. Diagnostic interviews
For diagnostic assessments we used the SCID for axes I and II (First et al. 1996, 1997)
and the GAF scale for Axis V, both based on the DSM-IV (American Psychiatric Association
1994). The Scales for the Assessment of Negative Symptoms (SANS, Appendix 2) and Positive
Symptoms (SAPS, Appendix 3) (Andreasen 1983, 1984) were used to evaluate the signs and
symptoms.
The interview questions and scoresheets were translated into Finnish. We added questions
on smoking, place of birth and some sociodemograpic variables to the overview scoresheet.
We made all ratings on a lifetime basis and used all available information, including
discussions with family members or health care personnel.
We first did a pilot study, interviewing and testing 39 patients. We started the interview
with the overview and then went through all modules of SCID-I, including the GAF. The
subjects then filled the SCID-II questionnaire, and for all items answered "yes" on the
questionnaire the interviewer continued to ask all questions concerning that specific
personality disorder. We continued with the SAPS interview if the subject had any
psychotic symptoms in SCID-I. The SANS interview was done first for all patients, but we
later used it for all subjects. The interview took approximately four hours on average. We
also constructed a family tree including all core family members and relatives known by
the subject. We generally completed the interview and performed the neuropsychological
tests on the same day. We continued on another day if the subject wanted or was tired.
The study protocol required the clinical study teams to first-contact the doctor or the
nurse in charge of the patient to obtain their participation in the study. All patients and
relatives provided written informed consent after the procedure had been explained to them.
The ethical review boards of Finland’s National Public Health Institute approved this study.
To contact all patients and their relatives around Finland we had four teams of field
workers. The field workers, who contacted treating personal, patients and their relatives,
were nurses, mental nurses and one doctor. All had been given extensive training in the
use of the instruments. To increase reliability we used tape-recordings and the senior
researcher reviewed the 20 first interviews of each fieldworker. The SCID-I-II, SANS and
SAPS interviews were also discussed with the senior researcher, with whom the interviewers
had regular consultations. The interviewers were blind to the consensus and register
diagnoses.
We did not assess the reliability of SCID interviews in our studies, but in other studies
the reliability of SCID-I (Skre et al. 1991, Williams et al. 1992, Miller et al. 2001) and
SCID-II (Williams et al. 1992, Osone and Takahasi 2003, Weertman et al. 2003) has been
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good. Nevertheless, it was difficult for the interviewers to remain completely blind to
the status of family members because the participants often wanted to discuss the
situation in their family and constructed the family tree.
6.6.2 Assessment of Negative and Positive Symptoms
SANS (Andreasen, 1983) (Appendix 2) consists of 25 items rated on a six-point scale (0-5)
in the interview. The five subscales of SANS are affective flattening or blunting, alogia,
apathy, asociality, and inattention. The signs of "affective flattening, alogia, and
affective blunting", such as mobility of facial expression, response to a stimulus such as
being smiled at, quality of eye contact, use of expressive gestures, etc, should be rated
using observation rather than by subjective evaluation (Andreasen 1989, Andreasen et al.
1995b).
SAPS (Andreasen 1984)(Appendix 3) consists of 34 items and is divided into four subscales:
hallucinations, delusions, bizarre behavior, and formal thought disorder.
All symptoms were rated based on the greatest lifetime-ever severity. We also used all other
available information, including discussions with health care personnel or family members.
The reliability of the various SANS and SAPS items has been assessed repeatedly and found
to be excellent, using both inter-rater and test-retest reliability measures, and they
have been translated into many languages (Andreasen 1989, 1995b). However, Norman and
colleagues (1996) found that levels of interrater reliability were lower than had been
reported in earlier studies. Mueser and colleagues (1994) found that the reliability of
SANS was good.
6.7. The genealogical studies in the isolate
We performed a genealogical search in accordance with published criteria for 263 families
from the isolate who gave a blood sample for the genetic study. The ancestors of the
patients were traced back for four to 12 generations from the local church registers and
the National Archives of Finland to reveal all consanguineous relatives. To estimate the
degree of familiality with each patient (Study III), we counted consanguineous patients
through all common founders in four-generation pedigrees. We counted the number of
consanguineous patients born 1940 to 1976 considering the liability classes of DSM-IV
diagnoses (Figure 3).
An overview of total numbers of subjects in the isolate, in the whole country multiplex
family and in Studies I-IV is presented in Table 4.
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Table 4. An overview of methods and subjects in studies I-IV
Study      Methods         Samples        N     Male Mean 
%  age
%  years
   Isolate study   Registers1)              Registers                         658     59 %   49.1
   total           Case records2,4)
                   Interviews3,5,6,7)       DSM-IV Consensus and OCCPI2,4)    326     64 %   49.9
Genealogical research8)
                                            Interview                         257     60 %   51.8
   Whole country   Registers1)              Registers                         4904    53 %   49.7
   multiplex
   total           Case records2,4)         DSM-IV Consensus and OCCPI2,4)    945     57 %   49.2
                   Interviews3,5,6,7)       Interview                         284     56 %   49.5
   Study I         Registers1)              Registers                         237     60 %   43.7
                   Case records2)           DSM-IV Consensus2)                164     67 %   43.7
                   SCID-I-II interviews3)   Interview                         131     66 %   43.6
   Study II        Registers1)              Isolate multiplex (IM)9)          78      74 %   50.6
                   Case records2)           Isolate singleton (IS)10)         112     67 %   47.1
OCCPI4)   Whole country (NM)11) multiplex   446     60 %   48.7
   Study III       Registers1)              Isolate singleton (IS)10)         113     66 %   47.5
                   Case records2)
                   SCID-I-II3), GAF5),      Isolate multiplex (IM)9)          63      70 %   50.3
SAPS6), SANS7),
                   Genealogical research8)   Whole country (NM)11) multiplex   94      59 %   46.3
   Study IV        Registers1)              Isolate patients                  124     65 %   46.0
                   SCID-I-II3),
                   GAF5),                   "Heathy" siblings                 183     49 %   46.1
SANS7) interviews
                                            Comparison group (Heath 2000)12)   111     50 %   50.3
1)  Registers: The Hospital Discharge, Free Medicine and Disability Pension 
2)  Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (American Psychiatric Association 1994)   
3)  Structured Clinical Interview I and II for DSM-IV (First et al. 1996, 1997)     
4)  Operational Criteria Checklist for Psychotic Illness (McGuffin et al. 1991)    
5)  Global Assessment of Functioning 
6)  Scale for the Assessment of Negative Symptoms (Andreasen 1983) 
7)  Scale for the Assessment of Positive Symptoms (Andreasen 1984)  
8)  263 isolate families
9)  Isolate multiplex patients had at least one sibling with psychotic disorder   
10) Isolate singleton patients had no first-degree relatives with any psychotic disorder according to register information
11) Whole country multiplex families have at least two affected sibling in the family    
12) Health 2000 study (Aromaa and Koskinen 2004) 
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6.8. Statistical analyses
6.8.1 Statistical analyses in Study I
Using Survo MM 2.05 for Windows, the lifetime prevalence was calculated as the number of
individuals born in the isolate and alive on 31 December 1998, who had received a
diagnosis of schizophrenia at some point during their life, divided by the number of
individuals born in the isolate and alive on 31 December 1998. The cumulative incidence
was calculated as the number of individuals born in the isolate who received a diagnosis
of schizophrenia at some point during their life divided by the number of individuals born
in the isolate during the same years.
Using SPSS 11.0 for Windows, we calculated descriptive statistics for the sample and for
frequencies of mental disorders. We also compared the three diagnostic assessments and
made cross tabulations for patients with a DSM-IV consensus diagnosis and SCID-I and -II
interview diagnosis, register and consensus diagnosis, and register and interview
diagnosis.
6.8.2 Statistical analysis in Study II
All OCCPI symptom items were coded dichotomously (Appendix 1): a missing item score was
assumed to mean no symptom. Items rated as present in at least 10% of subjects were
included in the analysis. Then, on the basis of the kappa values exceeding 0.46, thirty
OCCPI items were selected for use in the analyses. We thus excluded certain OCCPI items,
including bizarre behavior and delusions, delusions of passivity, primary delusional
perception, running commentary voices, other (non-affective) auditory hallucinations, and
non-affective hallucination in any modality.
We compared the symptom items in different groups (isolate singletons, isolate multiplex,
and multiplex family patients from the whole country) with the logistic regression model,
and then the pattern of symptoms using classification tree analysis. That analysis
produced a binary classification tree of response variable groups based on dichotomous
OCCPI criteria (Breiman et al. 1984).
The factor structure analysis was calculated from the tetrachoric correlation matrix and
rotated using VARIMAX rotation (Johnson and Wichern 1982). There was a good rationale for
four factors, as the fifth factor accounted for less than 10% of the variance. The four
factor solution was also common in other studies (Serretti et al. 1996, 1999, 2001,
McGorry et al. 1998, Van Os et al. 1999, Cardno et al. 1999, McIntosh et al. 2001, Murray
et al. 2005).
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6.8.3 Statistical analysis in Study III
We analyzed the dimensional nature of the individual 19 SANS and 29 SAPS items, and
excluded the global items (Study III, Appendix 2 and 3). We divided the material into
three groups: Isolate multiplex (N=63), Isolate singleton (N=133), and nationwide (whole
country) multiplex patients (N=94). First, we studied 3-7 factor solutions with VARIMAX
rotation (Johnson and Wichern 1982) of the isolate and whole country separately, although
the factor structures were fairly similar. Then, we calculated the scores of four factors
produced by the pooled data and compared them between the three groups. Comparisons were
made using linear regression models with group, sex, education, and age as explanatory
variables. We also made the comparison using the same method, but using the number of
affected consanguineous relatives as explanatory variable. Patients were divided into five
groups according to the number of consanguineous affected relatives: 1-5, 6-10, 11-15, and
over 15.
6.8.4. Statistical analysis in Study IV
Using SPSS 11.0 for Windows, we calculated the numbers and percentages of principal
SCID-I-II diagnosis, co-morbid mental disorders, as well as sociodemographic and clinical
characteristics in the groups of initially healthy siblings and the comparison group.
We took the within-family correlation into account by using conditional logistic
regression and general estimation equations (Zeger and Liang 1986) in our analysis. We had
family as the stratification variable, psychosis as the dependent variable, and age
(40-49, 50-59, 60-69 years), sex, residence (city, population centers, rural), contact for
mental health problems, contact for alcohol or substance use problems, and smoking as
explanatory variables. We also tested the results of 113 SANS interviews of initially
healthy siblings using the same logistic regression analysis, with the diagnosis of
psychosis as the dependent variable and the SANS items without global ratings as
explanatory variables. We also reanalyzed the register diagnoses seven years later.
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7. RESULTS
7.1 Prevalence and diagnosis of schizophrenia based on register,
case record and interview data in an isolated Finnish birth cohort
born 1940-1969 (Study I)
7.1.1 Lifetime prevalence and cumulative incidence
The lifetime prevalence of schizophrenia and schizophrenia spectrum psychotic disorders in
1998 according to the Hospital Discharge, Disability Pension and Free Medicine Registers
was 1.5%, and 1.9%, respectively. For schizophrenia spectrum psychotic disorders, it was
highest (2.4%) in birth cohorts born from 1950 to 1964. The cumulative incidence was
1.90%. We also estimated the lifetime prevalences based on consensus diagnoses and
interviews: the prevalences were 0.9-1.3% and 0.7-1.2%, respectively.
7.1.2 The register, case record, consensus and interview diagnoses of
schizophrenia
In the Hospital Discharge Register, 191 (81%) patients had schizophrenia as register
diagnosis. We identified only 17 (7%) patients in the Social Insurance Institution
registers without a diagnosis in the Hospital Discharge Register. We then used case
records to reassess the consensus diagnosis for 164 (69%) of 237 patients, 113 (69%) of
whom had a DSM-IV consensus diagnosis of schizophrenia. Finally, we interviewed 131
patients and 83 (63%) of them had an interview diagnosis of schizophrenia.
7.1.3. Comparison of register, consensus and interview diagnoses
When we compared the register diagnosis of schizophrenia, schizoaffective and
schizophreniform disorder (code 295 as inclusion criterion) with the DSM-IV consensus
diagnosis in 164 cases and with the SCID interview diagnoses in 131 cases, 140 (85%) and
113 (86%), respectively, had a schizophrenia diagnosis in the Hospital Discharge Register
(Tables 5 and 6).
The agreement between consensus and interview diagnoses in schizophrenia and
schizoaffective disorder was good (a match in 91% of the cases, see Table 7).
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Table 5. Comparison of register and consensus diagnoses (N=164)
                           DSM-IV consensus diagnosis1)
Register 1 diagnoses2) Lc 1 Lc 2 Lc 3 Lc 4 Lc 0   No dg   Total
Lc 1    101  20   2  13   4           140
Lc 2    2  3  1           6
Lc 3*                 6  1  2           9
Register 2,33)        4  1  2  1    1      9
Total                 113  24   5  16   5    1      164
1) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (American Psychiatric Association 1994)   
2) Hospital Discharge Register diagnoses   
3) Disability Pension and Free Medicine Register diagnoses    
   Liability classes: class 1= schizophrenia, class 2= schizoaffective disorder,  
   class 3= schizophreniform, delusional, shared psychotic, and brief psychotic disorder, and psychotic disorder NOS, 
   class 4= affective psychotic disorders, class 0= all other mental disorders   
*  only schizophreniform disorder
                                                            
                                                            
                                                            
                                                            
                                                            
                                                            
                                                                                                                      
Table 6. Comparison of register and interview diagnoses (N=131)
                           SCID-I-II interview diagnosis1)
Register 1 diagnoses2) Lc 1 Lc 2 Lc 3 Lc 4 Lc 0   No dg   Total
Lc 1    79 19   1  13   1           113
Lc 2    1  2  1  2           6
Lc 3*                 1  2  1  2           6
Register 2,33)        2  3    1      6
Total                 83   23   3  20   1    1      131
1) Structured Clinical Interview I and II for DSM-IV (First et al. 1996, 1997)
2) Hospital Discharge Register diagnoses 
3) Disability Pension and Free Medicine Register diagnoses   
   Liability classes: class 1= schizophrenia, class 2= schizoaffective disorder,  
   class 3= schizophreniform, delusional, shared psychotic, and brief psychotic disorder, and psychotic disorder NOS, 
   class 4= affective psychotic disorders, class 0= all other mental disorders   
*  only schizophreniform disorder
                                                            
                                                            
                                                            
                                                            
                                                            
                                                            
                                                            
                                                            
                                                                                                                      
Table 7. Comparison of consensus and interview diagnoses (N=131)
                           SCID-I-II interview diagnosis2)
Consensus diagnoses1) Lc 1 Lc 2 Lc 3 Lc 4 Lc 0   No dg   Total
Lc 1    72 13   7           92
Lc 2    6  9  1  2           18
Lc 3    2  1    1      4
Lc 4    4  10            14
Lc 0    1  1           2
No diagnoses          1           1
Total                 83   23   3  20   1    1      131
1) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (American Psychiatric Association 1994)  
2) Structured Clinical Interview I and II for DSM-IV (First et al. 1996, 1997)    
   Liability classes: class 1= schizophrenia, class 2= schizoaffective disorder,  
   class 3= schizophreniform, delusional, shared psychotic, and brief psychotic disorder,   
   psychotic disorder not otherwise specified,   
   class 4= affective psychotic disorder, class 0= all other mental disorders    
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7.2 Clinical phenotype of schizophrenia in a Finnish isolate
(Study II)
7.2.1 Frequency of symptoms between isolate and whole country patient
groups
We compared  the  presence of schizophrenia symptoms between the multiplex  (N=78)  and
singleton (N=112) patients in the genetic isolate and the multiplex family patients
(N=466) from the whole country and found significant differences between the three samples
in 11 individual OCCPI items. However, the classification tree analysis did not
discriminate the three patient groups from each other.
7.2.2. Clinical phenotype according to factor analysis
The factor analysis suggested that four distinct factors of the OCCPI variables accounted
for 55% of the variance. The factors were "Delusions and hallucinations", "Manic symptoms
and behaviour", "Negative" symptoms and "Depressive" symptoms. The basic phenotype
structure of schizophrenia in the isolate was similar to that in the multiplex families
representing familial schizophrenia in the whole of Finland.
7.3 Affective flattening and alogia associate with the familial
form of schizophrenia (Study III)
7.3.1. Comparison between isolate and whole country patient groups
The isolate singleton (IS) patients had significantly less symptoms of affective
flattening and alogia (factor 1) than isolate (IM) and nationwide (whole country) (NM)
multiplex family groups (p=0.01 and p=0.001, respectively). In "delusions and
hallucinations" (factor 3), there was again a significant difference, the IS (p=0.02) and
IM patients (p=0.01) presenting less symptoms than the NM patients. The IS patients had
significantly lower SANS scores than the two multiplex groups (p=0.02). In SAPS sums, the
NM patients had significantly more symptoms than the IS and IM patients (p=0.00007).
The demographic and clinical characteristics of isolate and whole country multiplex
patients are shown in Table 8.
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1) Isolate singletons patients had no first-degree relatives with any psychotic disorder  
2) Isolate multiplex patients had at least one sibling with psychotic disorder  
3) At least two affected siblings in the family from the whole country  
4) Global Assessment of Functioning 
5) Scale for the Assessment of Negative Symptoms (Andreasen 1983) 
6) Scale for the Assessment of Positive Symptoms (Andreasen 1984)
Table 8. Demographic and clinical characteristics of isolate and whole country 
multiplex patients (N=290)
Isolate singletons (IS)1) Isolate multiplex (IM)2) Multiplex whole country 
(NM)3)
Total Male Female Total Male Female Total Male Female
N   133  88   45  63   44   19  94   55   39  
Mean age, years           47.5 46.4 49.8 50.3 50.2 50.6 46.3 45.4 47.5 
(SD)     (9.6) (8.3) (11.4) (10.1) (10.2) (10.3) (8.9) (8.3) (9.5)
Age of onset              23.0 22.3 24.3 23.2 23.9 21.7 22.4 22.1 22.8 
(SD)     (6.3) (5.6) (7.3) (6.7) (7.4) (4.4) (5.7) (5.1) (6.5)
Education, years          9.8 9.9 9.7 9.5 9.4 9.7 9.6 9.6 9.6 
(SD)     (2.9) (2.6) (3.5) (2.5) (2.1) (3.2) (2.0) (2.2) (1.7)
Hospitalization:          
Number of admissions      15.6 14.8 17.1 16.2 12.9 24.4 11.0 12.7 8.7  
(SD)     (15.7) (14.8) (17.5) (19.7) (12.3) (30.2) (10.3) (12.3) (5.9) 
Mean duration, days       111.8 138.5 60.9 88.8 103.8 52.1 113.4 84.3 154.0
(SD)     (272.4) (328.1) (85.4) (142.9) (163.6) (59.7) (156.4) (149.5) (158.8)
GAF 1 year4)          39.1 38.3 40.7 33.9 35.6 29.9 38.2 37.9 38.6 
(SD)     (15.3) (14.8) (16.2) (9.7) (10.2) (7.0) (11.4) (10.5) (12.7)
SANS5) sum           50.9 51.2 50.3 60.3 62.5 55.4 57.1 59.9 53.3 
(SD)     (22.2) (21.7) (23.4) (22.7) (21.7) (24.5) (25.1) (25.4) (24.5)
SAPS6) sum                41.5 42.1 40.4 39.1 36.4 45.4 50.3 50.1 50.7 
(SD)     (19.8) (21.2) (17.0) (20.0) (18.6) (22.2) (20.6) (21.8) (18.9)
 patients had no first-degre  relatives with any psychotic disorder according to register information 
Whole country multiplex fam lies had at least two affected siblings
7.3.2 Phenotype according to factor analysis
The   factor  analysis   resulted  in  four   factors  of  which  two  were  negative:  "Affective
flattening and alogia" and "Anhedonia and social dysfunction", plus "Disorganization" and
"Delusions and hallucinations".
7.3.3. Influence of consanguinity
We observed no significant differences on the level of consanguinity (Figure 3), and
neither did the mean number of affected consanguineous relatives differ significantly
between the IS and (p=0.08) IM patients. Level of consanguinity did not correlate with any
of the factor scores, in contrast to the family history.
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7.4 Psychosis among initially healthy siblings of schizophrenia
patients (Study IV)
7.4.1 Psychotic disorders of initially healthy siblings
In the SCID-I interview, 30 (16.4 %) siblings received a diagnosis of psychotic disorder
among the 183 siblings with no register diagnosis of psychotic disorder in 1991. Fourteen
siblings (7.7%) had had psychotic symptoms before 1991 and sixteen (8.7%) developed
psychotic symptoms during the follow-up.
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Table 9. SCID-I-II1) diagnosis of 183 healthy siblings, and SCID-I diagnosis of 111
individuals from the comparison group.
In brackets are numbers of the 14 siblings who had psychotic symptoms before the register information was collected in 1991.
Isolate siblings Comparison group2)
183      111         
                          
Psychotic disorders
Schizophrenia            1 (1)  0.5 %        1 0.9 %
Schizoaffective disorder                 6 (2)  3.3 %
Delusional disorder                                  3 (1)  1.6 %
Psychotic disorder NOS                               8 (4)  4.4 %
Alcohol-induced psychotic disorders                  4 (3)  2.2 %        1  0.9 %
Other substance induced psychotic disorders          2 (1)  1.1 %
Major depressive disorder with psychotic features    4 (1)  2.2 %
Bipolar disorder I                                   2 (1)  1.1 %
                             
Other mental disorders
Other depressive disorders                           28 15.3 %        21 18.9 %
Personality disorders A3) *                7 3.8 %            not assessed
Personality disorders B4)-C5) *                  4 2.2 %            not assessed
Alcohol use disorders                7  3.8 %        14  12.6 %
Anxiety disorders                                    22 12.0 %        8   7.2 %
Other      1  0.5 %
Diagnosis         99 54.1 %        45  40.5 %
No diagnosis           84 45.9 %        66  59.5 %
SUM       183 99.9 %       111 100.0 %
1) Structured Clinical Interview I and II for DSM-IV (First et al. 1996, 1997)  
2) Health 2000 study (Aromaa and Koskinen 2004)  
3) Paranoid, schizotypal and schizoid personality disorders
4) Histrionic, narcissistic and borderline personality disorders  
5) Avoidant, dependent and obsessive-compulsive and not otherwise specified personality disorders  
* 5 siblings had SCID-II personality disorder without other diagnosis. Siblings had 43 (23%) co-morbid diagnoses: 15 (8.2%) alcohol use, 15 
anxiety (8.2%), and 6 (3.3%) other depressive disorders, 5 (2.7%) personality disorder (2 cluster A and 3 cluster B-C), one anxiolytic
dependence disorder and one hypochondriasis. Comparison group had 10 (9.0%) co-morbid diagnoses: 5 anxiety and 5 alcohol use disorders.
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Of  all  30  siblings  with an  interview  diagnosis of  psychotic  disorder,  only  seven  had  a
hospital treatment because of psychotic disorder between 1991 and 1998 according to the
Hospital Discharge Register, even though they all had psychotic symptoms prior to 1998
according to interview. Less than half (43%) had current psychiatric treatment or
medication and eight (28%) had current antipsychotic treatment.
7.4.2 Negative symptoms of initially healthy siblings
113 of 183 initially healthy siblings were interviewed with SANS (Appendix 2). Items 3
(Paucity of expressive gestures) and 15 (Impersistence at work or school) had
statistically significant odds ratios of 4.6 and 3.0 (CI 1.1-18.4, p=0.004 and CI 1.6-5.9,
p=0.001) respectively, and were associated with the diagnosis of psychotic disorder.
7.4.3. Siblings with initially no register diagnosis of psychosis compared
to the comparison group
Initially healthy siblings had significantly more diagnoses of psychotic disorders (16%
versus 2%, p<0.0001) than the comparison group (N=111), and 54% versus 41% had any mental
disorder in the SCID-I interview. The comparison group had higher current GAF ratings
(mean 79.2, SD 12.5 versus mean 73.7, SD 14.9, p=0.002) than the siblings.
An overview of aims and main results in different studies is given in Table 10.
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Table 10.  Overview of aims and main results in four studies.
Study I                   Study II       Study III                 Study IV
Aims:       Aim:                     Aim: Aim:
Prevalence of           Phenotype analysis of    Phenotype analysis of   Mental health of siblings
schizophrenia          schizophrenia according  schizophrenia according  of schizophrenia patients
to case record based     to interview based      
Cumulative incidence of   OCCPI1) ratings          SANS3) and SAPS4) ratings
schizophrenia,                       
schizoaffective and                   
schizophreniform                      
disorders                             
            
Reliability of diagnoses              
Results:                   
            
Prevalence of          Phenotype in the isolate Familial patients:      30 (16%) of initially  
schizophrenia was         was similar to whole               healthy siblings       
according to         Finland familial2)       more affective          received diagnosis of  
schizophrenia          flattening and alogia   some psychotic disorder
Register diagnoses 1.5%     than IS5) patients
Consensus diagnoses                   14 (7.7%) of 183       
0.9-1.3%                    Isolate patients:       initially healthy      
Interview diagnosis                   siblings had psychotic 
0.7-1.2%                  Four factors were found: less positive symptoms  symptoms before 1991,  
  than NM6) patients and 16 (8.7%) developed
1. "Delusions and                  symptoms during follow-up
Cumulative incidence  for    hallucinations"    Four factors were found:
schizophrenia,          2. "Manic"                         54% of initially       
schizoaffective and       3. "Negative"          1. "Affective flattening healthy siblings had   
schizophreniform disorder 4. "Depressive"          and alogia"       a lifetime diagnosis of
was 1.9% according to       2. "Disorganization"    any mental disorder in 
register data               3. "Delusions and        the interview         
  hallucinations"   
Of those with register      4. "Anhedonia and social
diagnosis         dysfunction"      
of schizophrenia,                     
schizoaffective                      
or schizophreniform         
disorder 69% had            
a consensus and 63%         
an interview diagnosis of   
schizophrenia.          
1) Operational Criteria Checklist for Psychotic Illness (McGuffin et al. 1991)   
2) Two or more family members affected     
3) Scale for the Assessment of Negative Symptoms (Andreasen 1983)   
4) Scale for the Assessment of Positive Symptoms (Andreasen 1984) 
5) Isolate singleton patients had no first-degree relatives with any psychotic disorder according to register information 
6) Whole country multiplex families have at least two affected siblings in the family   
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8. DISCUSSION
Our  main  findings  were  that  the  prevalence  of  schizophrenia  was relatively high in the
isolate as ascertained using register, case record or interview data, as was the lifetime
cumulative incidence. Of those with a register diagnosis of a schizophrenia-associated
psychotic disorder, 69% received a record-based consensus diagnosis and 63% an interview
diagnosis of schizophrenia. The isolate patients represented familial schizophrenia with
affective flattening and alogia as negative symptoms, and they had less positive symptoms.
Furthermore, 8.7% of initially healthy siblings received a diagnosis of psychotic disorder
during a relatively short follow-up. In addition, 7.7% of siblings had psychotic symptoms
already before the register diagnosis was identified.
8.1. Methods and methodological limitations
8.1.1. Registers and representativeness of study samples
The accuracy of the Finnish Hospital Discharge Register has been found to be excellent.
The primary diagnoses in the register and hospital case notes were identical in 99% of
schizophrenia cases (Keskimäki and Aro 1991).
Byrne et al. (2005) conducted a systematic review of studies investigating the
validity of administrative registers used in psychiatric research. They concluded that
there were relatively few high quality studies, and that methods and quality of studies
varied considerable. However, no gold standard exists for the assessment of register data
validity, and available studies mostly draw positive conclusions about the validity of
registers. The accuracy of the Disability Pension and Free Medicine Registers has not been
assessed. However, the proportion of patients who do not receive hospital treatment is
relatively small, less than 10% (Lehtinen et al. 1990, Lehtinen et al. 1991). In our study,
we identified from the Disability Pension and Free Medicine Registers just 17 patients (3%
of all patients) who did not receive hospital treatment.
Patients with a register diagnosis of other non-affective psychotic disorder, e.g.
delusional disorder or psychotic disorder not otherwise specified, were not included in
the study. Previous studies (Isohanni et al. 1997, Moilanen et al. 2003) have found that a
number of these patients actually have schizophrenia, so including these patients in our
study would probably have raised the prevalence of schizophrenia in these birth cohorts.
In addition, we excluded some schizophrenia spectrum disorders, e.g. paranoid, schizoid
and schizotypal personality disorders, from the register survey. However, these patients
might have manifested psychotic disorders and schizophrenia in the follow-up.
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In 1969, when the first hospitalizations were registered in the National Hospital
Discharge, Disability Pension and Free Medicine Registers, the patients born in 1940 were
29 years old. The mean age of onset was 28.2 years according to the register data, so we
might have missed some patients who had no further relapses and, in addition, some at the
other end with late onset of schizophrenia. In addition, the amount of psychiatric
inpatient beds decreased dramatically in Finland in 1990s, and this might have lead to the
more stringent indications of hospitalization. The prevalence might therefore have been
even higher.
In our study, the patients from the isolate and whole country, isolate siblings and
comparison group were all identified using the same unique representative extensive
Finnish health care registers. However, the inclusion criteria varied in studies I-IV.
In Study I, we analyzed the birth cohort (N=282) identified from the national population
register born from 1940 to 1969 in the isolate, contrary to studies II-IV with patients
having at least one parent born in the isolate. However, the study project was originally
designed mostly for genetic study purposes, and that placed on us the limitation that we
had not identified for genetic studies all those patients who were born in the isolate. We
had not contacted these patients without a parent born in the isolate or who refused from
the genetic study, and we did not reassess their register diagnoses or interview them. So
we had to estimate the lifetime prevalence based on interview and consensus diagnoses.
Based on register information, individuals who refused to participate in the study were
less severely affected than those who participated. Although this is a limitation in the
clinical study, from the perspective of the genetic study it is an advantage that families
having the most severely affected patients agreed to participate in the study.
In Study II, multiplex patients representing familial schizophrenia from the whole country
were identified using the same registers. We compared the singleton and multiplex family
patients from the isolate and whole country multiplex family patients; unfortunately we
could not compare the isolate patients to singleton patients from the whole country or
even to more heterogeneous populations (DeLisi et al. 2001). We included only consensus
diagnosis ascertained schizophrenia patients in our study. This limits comparison with
some other studies, which included schizophrenia plus other psychotic disorders (Kendler
et al. 1998), but improves the validity of our analyses. In addition, we constructed
extensive isolate pedigrees, which showed us all the complex genealogical connections in
four generations. The information was used in analyses in Study III.
In Study III, we had the same limitation as in Study II, i.e. lack of a singleton patient
sample from the whole country, and so could not compare our finding to the average
schizophrenia rates found in Finland. The genealogical study designed to reveal all
consanguineous relatives of schizophrenia patients was conducted exclusively in the
isolate, so comparisons between the isolate and whole country multiplex family samples
were not possible.
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In Study IV, we could not contact or interview all healthy siblings (N=1353), which might
have influenced our results. We aimed to interview at least one sibling nearest in age to
every patient; however, we did not take into account the age differences between the
siblings. We had 124 patients and 183 siblings with no register based diagnosis of
psychosis in 110 families, and we took into account the within-family correlation in our
statistical analysis.
The comparison group we had was a representative sample of the Finnish general population,
but it might not be representative of the population originating from the isolate.
8.1.2 Case record collection and consensus diagnosis based assessments
We collected all available original case notes. The case notes were insufficient in five
cases. In the isolate, kappa values for the best-estimate diagnosis were good to
excellent, as they were also for the whole country multiplex family sample. Assessing
consensus diagnoses in this way has emerged as reliable in many previous studies (Leckman
et al. 1982, Goodman et al. 1984, Craddock et al. 1996, McConville and Walker 2000).
The reliability assessment of the register diagnoses we used in our diagnostic assessment
is almost identical to that used by Isohanni et al. (1997) and Mäkikyrö et al. (1998). The
study by Mäkikyrö and colleagues (1998) was based on the first 73 patients who
participated in the genetic study in the early 1990s and, unsurprisingly, our results were
quite similar. In the smaller sample, 87% of the patients obtained a diagnosis of
schizophrenia, compared with 69% in our total sample, and 90% vs. 87% respectely had any
schizophrenia associated psychotic disorder (Mäkikyrö et al. 1998). The most densely
affected families were contacted first, which explains the slightly better reliability of
register diagnoses found in that study.
In contrast, (Isohanni et al. 1997, Moilanen et al. 2003) found in the Northern Finland
1966 Birth Cohort that all persons who had received a register diagnosis of schizophrenia
also fulfilled DSM-III-R diagnostic criteria for schizophrenia; however, there were 43%
false negative cases having a register diagnosis of psychosis other than schizophrenia.
Nevertheless, this cohort was substantially younger than ours and had shorter duration of
illness. It had, more over, been treated during the era in Finnish psychiatry when it was
customary not to give a diagnosis of schizophrenia after the first hospital treatments
due to psychosis, even if the diagnostic criteria were met.
This was consistent with a studies of first-admission patients, which found that Finnish
clinicians underdiagnosed schizophrenia (Pakaslahti 1987, Taiminen et al. 2001). Thus, in
line with other studies, we conclude that the register diagnosis should be reassessed for
genetic research (Moilanen et al. 2003, McConville and Walker 2000).
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8.1.3 The Operational Criteria Checklist for Psychotic Illness ratings
Serretti and Olgiati (2004) summarized some limitations of existing studies. The samples
are often too small and not adequately balanced in their composition. Too few non-
psychotic symptoms are analyzed. The prevalence rates of symptoms are generally adequate
in overall samples but not in individual diagnostic subgroups. Most studies include
exploratory but not confirmatory factor analyses.
In our study, the Operational Criteria Checklist for Psychotic Illness (OCCPI) rating was
based on the case notes for over 650 patients, blind to the register diagnosis. Thirty
OCCPI items were selected for the analyses. However, the selection of OCCPI items also
influences the factor structure (Kendler et al. 1998), and the exclusion of items may have
affected our results derived from the four-factor solution. However, the results for all
80 psychotic and affective items also yielded a four-factor solution, which was very
similar to the one with 30 items.
The choices made in analyses represent another potential influence on results. However,
Serretti and colleagues (1999) replicated the factor analysis with four factors using two
different methods (confirmatory and exploratory factor analysis) in two independent
samples. We included only schizophrenia patients in this study, which limits the
comparison to other studies, but improves validity. Only one study had exclusively
schizophrenia patients (Wickham et al. 2001). However, RDC criteria for schizophrenia were
used, which required a shorter duration of symptoms (only two weeks instead of six months
of DSM-IV) and complicates comparisons.
8.1.4. Interview based assessments
We observed good diagnostic agreement between the register diagnosis of schizophrenia and
SCID diagnoses, in contrast to the findings of Taiminen et al. (2001) with a sample of
first-admission psychosis. However, the patients were younger in that study and the
follow-up time was longer in ours.
Our interviewers were nurses, mental nurses and one doctor. We did not assess the
reliability of SCID interviews, but we improved their reliability by intensive training
and audio taping the first 20 SCID interviews of every interviewer. The agreement for SCID
interview based schizophrenia diagnoses has been high, as assessed from audio taped
material (Skre et al. 1991) and using the test-retest method (Williams et al. 1992).
The SCID interview assesses affective symptoms better than a consensus diagnosis made from
case records, because in clinical practice affective symptoms among patients with severe
positive psychotic symptoms are sometimes ignored (Taiminen et al. 2001). Further, Roy and
colleagues (1997) pointed out in their methodological study of 134 patients from large
multigenerational pedigrees densely affected by bipolar disorders or schizophrenia that
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the most problematic diagnostic distinctions involved schizoaffective disorder, which is
easily confused with schizophrenia, bipolar I and schizophreniform disorders.
In our study, 12 (40%) of siblings with no register diagnosis received a diagnosis of
schizoaffective or affective psychotic disorder, but some of these siblings clustered in
two families with several members with schizoaffective or affective psychotic disorders.
However, several family studies have reported that families have high risk not only for
schizophrenia and schizoaffective disorders but also for affective psychotic disorders
(Kendler et al. 1993a,b, Chang et al. 2002, Maier et al. 2002).
8.1.5 Assessment of negative and positive symptoms
SANS covers 19 negative symptoms, compared with relatively few items assessing negative
symptoms in OCPPI. Thus, using individual SANS and SAPS items instead of global scores
gives a more detailed view of signs and symptoms of schizophrenia, especially negative
symptoms. Ratings of affective flattening and alogia (diminished expression) reflect
behaviors evident during direct observation within a clinical interview. These might vary
more than anhedonia and social dysfunction, which are more of a reflection of global
social engagement occurring in the community (Blanchard and Cohen 2005). However, to
improve reliability, Andreasen (1989) has recommended that SANS and SAPS ratings should
ideally be based on multiple sources of information. This is what we aimed to do.
8.1.6 Genealogical studies
Only the family history or status of first-degree relatives correlated with the factors
"affective flattening" and "delusions and hallucination", contrary to the degree of
familiality counted from four-generation pedigrees. However, on the basis of the
genealogical study, all patients in the homogeneous isolate represented familial
schizophrenia. We have also previously reported that practically all people in our isolate
born before 1940s are in fact related to one another through numerous genealogical links
(Hovatta et al. 1999, Varilo et al. 1996, 2003). The genealogical study was conducted
exclusively in the isolate, which made the comparison with the multiplex families from the
whole country impossible.
8.1.7. Statistical methods
In Studies II and III we included all items rated as present in at least 10% of subject for
factor analysis. So, after OCCPI reliability assessments we included 30 OCCPI items, 19
SANS and 29 SAPS items in our analyses. All SANS and SAPS items were included except
"Clanging" and "Inattentiveness during testing". In the OCCPI factor analysis, we
dichotomized the items and excluded several of them, on the basis of the kappa values;
this might have affected our results. However, our study was comparable with other
investigations (Table 1). The factor analyses were calculated using VARIMAX rotation
(Johnson and Wichern, 1982) and both analyses had good rationale for four factors, as in
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many other OCCPI studies (Serretti et al. 1996, 1999, 2001; McGorry et al. 1998; Van Os et
al. 1999; Cardno et al. 1999; McIntosh et al. 2001; see Table 1), but most SANS and SAPS
factor analyses resulted in five factors (Toomey et al. 1997, Emsley et al.2001, McGrath
et al. 2004b, Niehaus et al. 2005) or even 11 factors (Peralta and Cuesta 1999, Table 2).
However, the factors affective flattening and alogia, disorganization, delusions and
hallucinations and anhedonia and social dysfunction are common to other studies, and there
was a good rationale for four factors, while the fifth factor accounted for less than 10%
of the variance. So, our results are consistent with other studies, showing that the
methods were reliable.
In the isolate, multiple affected patients and siblings were from the same families and
observations were thus not independent. We took the within-family correlation into account
by using conditional logistic regression and general estimation equations ( Zeger and
Liang 1986) in our analysis. However, there were numerical convergence problems in some
models, probably due to small cluster sizes, and we were able to model only part of the
analysis using the general estimation equations method.
8.2 Lifetime prevalence and cumulative incidence (Study I)
For the birth cohorts born 1940-69 in the isolate, the lifetime register based prevalence
of schizophrenia in 1998 was 1.5%, and of schizophrenia associated psychotic disorders was
1.9%. The cumulative incidence of schizophrenia associated psychotic disorders in the
total birth cohort was also 1.9%. This is high compared to Goldner’s et al. (2002)
systematic review analysis of best-estimate lifetime prevalence for schizophrenia of 0.55%
(0.37 to 0.8), or for schizophrenia spectrum disorders of 1.45% (0.8 to 2.37). However,
other isolates with high prevalence of schizophrenia have been described. In Puerto Rico,
the lifetime prevalence for the age range 17-64 years in 1984 was 1.6% for schizophrenia
and 1.8% for schizophrenia spectrum disorders (Canino et al. 1987). The prevalence in an
isolated rural area of North Sweden in 1977 was also high, at 1.7% (Böök et al. 1978).
In our study, the register-based lifetime prevalence of schizophrenia (1.5%) among
individuals born in the isolate was higher than in other parts of Finland. However, the
DSM-IV consensus diagnosis- or SCID interview-based prevalences (0.9-1.3 and 0.7-1.2%)
are rather similar to other Finnish studies: the cumulative incidence in the Northern
Finland 1966 Birth Cohort was 0.9% (Isohanni et al. 2001), and the lifetime prevalence in
the Mini Finland Health Survey was 1.3% for those aged 30 or over (Lehtinen et al. 1990).
Patients with a register diagnosis of other non-affective psychotic disorders, e.g.
delusional disorder or psychotic disorder not otherwise specified, were not included in
the study. In previous studies, it was found that a number of these patients actually have
schizophrenia, so including these patients in our study would probably have raised the
prevalence of schizophrenia.
64
In our study, the lifetime prevalence of schizophrenia was highest (2.4-2.5%) in the age
groups 39-53 years born 1945-59 in the isolate. At that time, the study region was among
the least developed parts of Finland. Moreover, during the 1950s infant mortality was
high: 38.5 infant deaths per 1000 live births compared to 29.4 in the whole country
(Palmgren, Official Statistics of Finland 1964). The occurrence of schizophrenia was lower
in the birth cohorts of 1960-64 (1.5%) and 1965-69 (1.0%), which accords with the
previously observed decline in the schizophrenia incidence in birth cohorts born from 1954
to 1965 (Suvisaari et al. 1999).
In Denmark by contrast, the first-admission rates of schizophrenia initially decreased and
have then been increasing since the late 1980s in register based studies (Munk-Jørgensen
and Mortensen 1992, Tsuchiya and Munk-Jørgensen 2002). In Finland, public health care has
improved and the proportion of hospital deliveries has increased considerably since the
1960s (The Official Statistics of Finland 1972). On the other hand, patients born in the
1960s had not lived through the whole risk period for schizophrenia. The oldest patients,
born 1940 to 1945, also had a lower occurrence of schizophrenia, but as the registers were
computerized only in 1968 the numbers might be inaccurate. Mortality had no effect on the
prevalence, as the cumulative incidence and lifetime prevalence were almost identical.
8.3. The phenotype in the isolate is similar to familial
schizophrenia in the whole of Finland (Study II)
Four factors, "delusions and hallucinations", "manic", "negative", and "depressive", were
detected in the genetic isolate of 190 patients with a DSM-IV diagnosis of schizophrenia.
Hence, we found that the clinical phenotype of schizophrenia in the isolate resembled that
found among patients with at least two affected family members from the whole country
(patients with familial schizophrenia), regardless of whether the isolate patients were
the only affected individuals in their family or not. Many studies have suggested that
familial schizophrenia may represent a more severe form of the disorder, with more
negative (Verdoux et al. 1996, Malaspina et al. 2000, Ross et al. 2000), or disorganized
(Cardno et al. 1997, Van Os et al. 1997, Wickham et al. 2001) symptoms. Thus,
schizophrenia in a genetically isolated population with a high lifetime prevalence of
schizophrenia represents familial schizophrenia as it manifests in pedigrees densely
affected with schizophrenia. For genetic studies, four factors that are well demarcated
provide a useful alternative to classical diagnostic systems. These four factors were used
as phenotypic traits in a genetic study that provided further evidence that the DISC1 gene
might be involved in the etiology of schizophrenia (Hennah et al. 2003).
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8.4 Affective flattening and alogia associate with the familial
form of schizophrenia (Study III)
Patients with at least one psychotic affected sibling, both in the isolate and nationwide
samples, suffered more than singletons from severe affective flattening and alogia, such
as paucity of expressive gestures, decreased spontaneous movements, unchanging facial
expression, and poor eye contact. Moreover, the level of functioning (GAF) was lower and
the sum of negative symptoms was significantly higher in these groups compared with the
isolate patients who were the only affected individuals in their family. However, the
isolate patients, regardless of their familial loading for schizophrenia, had less
delusions and hallucinations than the whole country multiplex patients, which may be
related to the genetic homogeneity in the isolate.
Concordant with this finding we found the negative symptoms "Paucity of expressive
gestures" and "Lack of vocal inflections" to be phenotypic features in initially healthy
siblings that could benefit genetic analysis in addition to clinical diagnoses (Study IV).
However, SANS has not been validated or even used in a general population. So, our result
that paucity of expressive gestures and lack of vocal inflections associate with psychosis
in siblings is preliminary.
Our finding indicating an association between negative symptoms and familiality agrees
with most previous twin, adoption, and family studies (Dworkin and Lenzenweger 1984, Burke
et al. 1996, Verdoux et al. 1996, Kendler et al. 1997, Van Os et al. 1997, Wickham et al.
2001, Cardno et al. 2002b). However, this was not the outcome to emerge from analysis of
the Roscommon data, which suggested that negative symptoms did not predict family
characteristics (Kendler et al. 1994b), nor from the study of DeLisi and colleagues (1987)
of siblings with schizophrenia or schizoaffective disorder.
We found four factors in our factor analysis of SANS and SAPS: two of the factors in SANS
were "Affective flattening and alogia" and "Anhedonia and social dysfunction", as in other
studies of SANS and SAPS (Table 2, Minas et al. 1994, Peralta and Cuesta 1999), and
studies analyzing exclusively SANS items (Mueser et al. 1994, Peralta and Cuesta 1995,
Sayers et al. 1996). Negative symptoms have repeatedly emerged as a separate factor,
independent of positive symptoms, disorganization and affective symptoms. The most
reliable factors within negative symptoms include diminished expression (symptoms of
affective flattening and alogia) and a factor tapping anhedonia and asociality (composed
of symptoms of anhedonia, diminished interest, and decreased social engagement) (Blanchard
and Cohen 2005).
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In our study, the two negative factors are concordant with these factors. In addition, we
had a preliminary finding of negative SANS factors being associated with the diagnosis of
psychosis in healthy siblings (Study IV). These results could limit the phenotypic
heterogeneity of schizophrenia and might allow for the identification of a subtype for
further studies.
8.5. Psychosis among initially healthy siblings of schizophrenia
patients (Study IV)
Our results clearly show that nationwide health care registers cannot be used to exclude
psychotic disorders in relatives of patients with schizophrenia. In 1991 7.7% of the
siblings who were presumed healthy based on Hospital Discharge Register actually had
psychotic symptoms. The number of false negatives would be high enough to jeopardize the
results of genetic analyses, if these siblings were treated as unaffected in the analyses.
Even if the initially healthy siblings were treated as unknown, as is often the case, the
analyses would have compromised statistical power compared to more exact diagnoses. This
finding of false negative cases was concordant with the latest Finnish studies assessing
the reliability of register diagnoses (Isohanni et al. 1997, Moilanen et al. 2003,
Taiminen et al. 2001). However, as Byrne and colleagues (2005) concluded in their review
article, there are relatively few high quality studies addressing this issue.
The rate of emergence of new psychotic disorders among siblings during the relatively
short follow-up time of this study was also high. Between 1991 and 1998, 8.7% of the
siblings developed any psychotic disorder, although their mean age in 1991 was already 37
years. The high rate of new-onset psychotic disorders reflects the fact that many siblings
came from multiply affected families.
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9. CONCLUSIONS AND IMPLICATIONS
9.1. Conclusions
The register-based prevalence of schizophrenia in this genetic homogenous isolate was
relatively high (1.5%). The prevalence of schizophrenia associated disorders was also
high (1.9%), and especially so among those born 1940 to 1959 (2.4%). In addition, the
prevalence of schizophrenia, based on DSM-IV consensus diagnoses and SCID interviews, was
high (0.9-1.3% and 0.7-1.2%, respectively). The cumulative incidence of schizophrenia
associated psychotic disorders including all deaths was 1.9%. Of those with a register
diagnosis of schizophrenia associated psychotic disorders, 69% or 63% also received a
record based consensus diagnosis or SCID interview diagnosis of schizophrenia. For
molecular genetic research work the register diagnosis should be reassessed using either a
structured interview or a best-estimate consensus diagnosis.
OCCPI phenotype analysis resulted in four factors: "Delusions and hallucinations" and
"Negative" factors, and two affective ("Manic" and "Depressive") factors. Our findings
suggest that the basic phenotype structure of schizophrenia in this isolated and
homogeneous population is similar to that in the multiplex families representing familial
schizophrenia in the whole of Finland.
Schizophrenia patients having first-degree relatives with psychotic disorder had more
severe negative symptoms with affective flattening and alogia than those who were the only
affected individual in the family. Moreover, the isolate patients, regardless of their
familial loading for schizophrenia, had less delusions and hallucinations than the whole
country multiplex patients. This finding may be related to the genetic homogeneity in the
isolate.
Absence of a register diagnosis cannot be used in molecular genetic studies to confirm
that siblings of patients with schizophrenia diagnosis are healthy. During a relatively
short follow-up, almost one tenth (8.7%) of initially healthy siblings developed psychotic
disorder. The risk of emergence of new psychotic disorders among initially healthy
siblings should be taken into account in genetic analysis. This finding also encourages
the use of endophenotypes in genetic analyses instead of reliance on psychiatric diagnoses only.
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9.2. Clinical implication
The use of structured clinical interview allowed us to identify patients with psychotic
and other mental disorders better and earlier than traditional diagnostic assessments. It
also helped us to recognize the negative symptoms of schizophrenia patients. Hence, the
structured diagnostic interview should be routinely used, not only in research but also in
clinical practice.
In our study, almost three-quarters of initially healthy siblings of schizophrenia patients
with psychotic disorders had had contact with health care professionals for mental health
problems and alcohol or substance use problems, compared to one third of non-psychotic
siblings. However, less than half of siblings with any lifetime diagnosis of psychotic
disorder had current psychiatric treatment. This suggests that when persons who have
relatives with schizophrenia or schizophrenia associated disorders seek help for any
mental, alcohol or substance use problems, psychotic symptoms should always be assessed
carefully using clinical interview methods.
9.3. Implications for future research
The registers in psychiatric research are excellent for identifying psychotic patients,
since about 90% of patients have been hospitalized. However, there has been little
systematic investigation of the validity of registers. So, register information should be
cross validated with interview studies to benefit future research.
The findings from phenotype studies of negative and positive symptoms of schizophrenia
patients and negative symptoms of initially healthy siblings should encourage further
research. Thus, both the negative symptom factors, "Affective flattening and alogia" and
"Anhedonia and social dysfunction", and also the positive symptoms factor "Delusions and
hallucinations", might benefit genetic analysis in addition to clinical diagnosis.
The search for new phenotypic clusters based on signs and symptoms should be encouraged.
The ultimate goal might be the division of classic schizophrenia into more specific
subdivisions reflecting the possible specific genetic etiology of schizophrenia in each
family.
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12. APPENDIX
12.1 Appendix 1
Operational Criteria Checklist Version 3.31 (McGuffin P, Farmer A, Harvey I, 1991)
     1. Source of rating (1-6)
     2. Time frame (1-4)
     3. Sec code (male 0, female 1)
     4. Age of onset
     5. Mode of onset (1-5)
     6. Single (married 0, single 1)
     7. Unemploeyed (employed 0, Unemployed 1)
     8. Duration of illness in weeks
     9. Poor premorbid work adjustment (0, 1)
    10. Poor premorbid social adjustment (0,1)
    11. Premorbid personality disorder (0, 1)
    12. Alcohol/drug abuse within one year of onset (0, 1)
    13. Family history on schizophrenia (0, 1)
    14. Family history of other psychiatric disorder (0, 1)
    15. Coarse brain disease prior to onset (0, 1)
    16. Definite psychosocial stressor prior to onset (0, 1)
APPEARANCE AND BEHAVIOR
    17. Bizarre behavior (0,1)
    18. Catatonia (0, 1)
    19. Excessive activity (0-2)
    20. Reckless activity (0-2)
    21. Distractibility (0-2)
    22. Reduced need for sleep (0-2)
    23. Agitated activity (0-3)
    24. Slowed activity (0-3)
    25. Loss of energy/tiredness (0-3)
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SPEECH AND FORM OF THOUGHT
    26. Speech difficult to understand (0, 1)
    27. Incoherent (0, 1)
    28. Positive formal thought disorder (0, 1)
    29. Negative formal thought disorder (0, 1)
    30. Pressured speech (0-2)
    31. Thought racing (0-2)
AFFECT AND ASSOCIATED FEATURES
    32. Restricted affect (0,1)
    33. Blunted affect (0, 1)
    34. Inappropriate affect (0, 1)
    35. Elevated mood (0, 1)
    36. Irritable mood (0, 2)
    37. Dysphoria (0-3)
    38. Diurnal variation (mood worse mornings) (0, 1)
    39. Loss of pleasure (0-3)
    40. Diminished libido (0, 1)
    41. Poor concentration (0-3)
    42. Excessive self reproach (0-3)
    43. Suicidal ideation (0-3)
    44. Initial insomnia (0-3)
    45. Middle insomnia (broken sleep) (0, 1)
    46. Early morning waking (0-3)
    47. Excessive sleep (0-3)
    48. Poor appetite (0-3)
    49. Weight loss (0-3)
    50. Increased appetite (0-3)
    51. Weight gain (0-3)
    52. Relationship psychotic / affective symptoms (0-4)
    53. Increased sociability (0-2)
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ABNORMAL BELIEFS AND IDEAS
    54. Persecutory delusions (0, 1)
    55. Well organized delusions (0, 1)
    56. Increased self esteem (0-2)
    57. Grandiose delusions (0, 1)
    58. Delusions of influence (0, 1)
    59. Bizarre delusions (0, 1)
    60. Widespread delusions (0, 1)
    61. Delusions of passivity (0, 1)
    62. Primary delusional perception (0, 1)
    63. Other primary delusions (0, 1)
    64. Delusions and hallucinations last for one week (0, 1)
    65. Persecutory / jealous delusions and hallucinations (0, 1)
    66. Thought insertion (0, 1)
    67. Thought withdrawal (0, 1)
    68. Thought broadcast (0, 1)
    69. Delusions of guilt (0, 1)
    70. Delusions of poverty (0, 1)
    71. Nihilistic delusions (0, 1)
ABNORMAL PERCEPTIONS
    72. Thought echo (0, 1)
    73. Third person auditory hallucinations (0, 1)
    74. Running commentary voices (0, 1)
    75. Abusive /accusatory / persecutory voices (0, 1)
    76. Other (non affective) auditory hallucinations (0, 1)
    77. Non-affective hallucinations in any modality (0, 1)
SUBSTANCE ABUSE OR DEPENDENCE
    78. Lifetime diagnosis of alcohol abuse /dependence (0, 1)
    79. Lifetime diagnosis of cannabis abuse /dependence (0, 1)
    80. Lifetime diagnosis of other abuse / dependence (0, 1)
    81. Alcohol abuse /dependence with psychopathology (0-1)
    82. Cannabis abuse / dependence with psychopathology (0-1)
    83. Other abuse / dependence psychopathology (0-1)
GENERAL APPRAISAL
    84. Information not credible (0, 1)
    85. Lack of insight (0, 1)
    86. Rapport difficult (0, 1)
    87. Impairment / incapacity during disorder (0-3)
    88. Deterioration from premorbid level of function (0, 1)
    89. Psychotic symptoms respond to neuroleptics (0, 1)
    90. Course of disorder (1-5)
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12.2 Appendix 2.
SCALE FOR THE ASSESSMENT OF NEGATIVE SYMPTOMS (SANS)
(Andreasen 1983)
AFFECTIVE FLATTENING OR BLUNTING
     1. Unchanging facial expression
     2. Decreased spontaneous movements
     3. Paucity of expressive gestures
     4. Poor eye contact
     5. Affective non-responsivity
     6. Inappropriate affect
     7. Lack of vocal inflections
     8. Global rating of affective flattening
ALOGIA
     9. Poverty of speech
    10. Poverty of content of speech
    11. Blocking
    12. Increased latency of response
    13. Global rating of alogia
AVOLITION - APATHY
    14. Grooming and hygiene
    15. Impersistence at work or school
    16. Physical anergia
    17. Global rating of avoliton - apathy
ANHEDONIA - ASOCIALITY
    18. Recreational interests and activities
    19. Sexual activity
    20. Ability to feel intimacy and closeness
    21. Relationships with friends and peers
    22. Global rating of anhedonia - asociality
ATTENTION
    23. Social inattentiveness
    24. Inattentiveness during mental status testing
    25. Global rating of attention
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12.3 Appendix 3.
SCALE FOR THE ASSESSMENT OF POSITIVE SYMPTOMS (SAPS)
(Andreasen 1984)
HALLUCINATION
     1. Auditory hallucination
     2. Voices commenting
     3. Voices conversing
     4. Somatic or tactile hallucinations
     5. Olfactory hallucinations
     6. Visual hallucinations
     7. Global rating of hallucinations
DELUSIONS
     8. Persecutory delusions
     9. Delusions of jealousy
    10. Delusions of guilt or sin
    11. Grandiose delusions
    12. Religious delusions
    13. Somatic delusions
    14. Delusions of reference
    15. Delusions of being controlled
    16. Delusions of mind reading
    17. Thought broadcasting
    18. Thought insertion
    19. Thought withdrawal
    20. Global rating of delusions
BIZARRE BEHAVIOR
    21. Clothing and appearance
    22. Social and sexual behavior
    23. Aggressive and agitate behavior
    24. Repetitive or stereotyped behavior
    25. Global rating of bizarre behavior
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POSITIVE FORMAL THOUGHT DISORDER
    26. Derailment
    27. Tangentiality
    28. Incoherence
    29. Illogicality
    30. Circumstantiality
    31. Pressure of speech
    32. Distractible speech
    33. Clanging
    34. Global rating of positive formal thought disorder
INAPPROPRIATE AFFECT
    35. Inappropriate affect
